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Apoptolidin C is a biologically active polypropionate macrolide isolated from the soil bacteria 
Nocardiopsis sp.  The work presented herein highlights a novel approach to synthesizing the core 
of the natural product, apoptolidinone C, as well as a de-novo synthesis of the C9 sacharide.  Our 
synthesis utilizes a catalytic asymmetric approach to the construction of the complex 
polypropionate arrays contained in apoptolidin through the use of our acyl halide-aldehyde 
cyclocondensation (AAC) reaction.  Employing the AAC technology using cinchona alkaloid 
derived catalysts, as well as the complementary chiral aluminum catalysts, we have successfully 
demonstrated a catalytic and asymmetric synthesis of the aglycone core of apoptolidin C.   In 
addition, we have demonstrated the asymmetric synthesis of the C9 saccharide from achiral 
starting materials.   
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1.0  INTRODUCTION 
1.1 ISOLATION AND BIOLOGICAL ACTIVITY 
Apoptolidin is a highly unsaturated twenty membered macro-lactone isolated in 1997 from the 
soil bacteria Nocardiopsis sp.
1
  Seto and coworkers initiated biological studies on apoptolidin A 
and found it to selectively and potently inhibit of the growth of rat glia cells transformed with the 
E1A oncogene.
1,2
  Apoptolidin has shown potent apoptosis induction in a number of cancer cell 
lines, and was found to be among the most selective (top 0.1%) agents tested against the National 
Cancer Institute’s (NCI) 60-cell line screening panel.3  An important aspect of apoptolidin A’s 
selectivity is the almost complete lack of toxicity in normal cells, even at high concentrations (>1 
mM).
1
   Elucidation of the structure and absolute configuration was achieved by spectral 
methods as well as chemical degradation.
2
  The structure was later confirmed through total 
synthesis by Nicolaou.
4
  In 2005, after numerous synthetic efforts had begun on apoptolidin A, 
Wender improved upon the original fermentation method of isolation of apoptolidin A, and 
increased the yield to 130 mg/L from 108 mg/L of fermentation medium.
5
  Wender also isolated 
two additional components from the fermentation mixture that lacked hydroxyl functionality at 
the C16 and C20 carbons (Figure 1) in 2-5 mg/L quantities.  These additional components were 
further identified as apoptolidins B and C due to their similarity with the already known 
macrolide.  Further investigation led to the discovery of apoptolidins D-F, which show similar 
biological activity, excluding apoptolidin F which showed drastically reduced activity due to its 
lack of the C27 disaccharide.
6
  The availability of the other members of the apoptolidin family is 
 2 
limited to a few milligrams per liter of fermentation medium, and as such, biological testing of 
the other compounds is incomplete. 
 
 
Figure 1. Apoptolidins A-F 
 
Biological testing of apoptolidins A-F demonstrated B to be the most potent, with A and 
C showing similar activity in growth inhibition asssays with the H292 cancer cell line for lung 
carcinomas (Table 1).
5
  Though extensive testing on the complete biological profile of 
apoptolidin C has not been completed to date, its activity against a number of biological targets 
is of great interest due to the impressive results shown by apoptolidin A.  
 3 
Table 1. Tabulated Biological Data 
 
1.2 MECHANISM OF ACTION 
Apoptolidin A has been shown to exhibit an activity profile that is analogous to that of other 
known F0F1-ATPase inhibitors.
7
  Khosla hypothesized that the inhibition of mitochondrial ATP 
synthase is the cause of the anti-proliferative affect exhibited in cells expressing cancer.
3
  One 
problem with this hypothesis is the apparent contradiction between in vitro and in vivo assays.  In 
cell-free assays of yeast mitochondrial ATP synthase apoptolidin A exhibits micromolar 
inhibition of ATP hydrolysis.
7
  These results however, conflict with the nanomolar inhibition 
attained in a cell proliferation assay using cells transfected with E1A and E1B oncogenes (table 
1).
7
  The assay results imply that apoptolidin A is approximately 100 times more potent against 
whole cancer cells than the biological target within the cell.  
 4 
There are a few possibilities that could explain the incongruity between the assay results.  
Since catalysis of ATP hydrolysis is not equivalent to ATP synthesis, it is possible that the cell-
free yeast F0F1-ATPase assay, which directly measures hydrolysis of ATP, is not an adequate 
measure of ATP synthesis, and therefore anti-proliferative activity.  Another explanation for 
those conflicting results would be that there is a relevant secondary biological target playing a 
role in the biological activity of apoptolidin A.
7-9
  
There is still much work to be done on elucidating the mechanism of action for 
apoptolidin A.  Due to the structural similarity, the results obtained may correlate well to the 
action of apoptolidin C, which up to this point demonstrates a very similar inhibition profile to 
apoptolidin A.
5
  Total syntheses of apoptolidin A have been published, along with numerous 
partial syntheses and fragments, however to date, there are no synthetic studies directed at 
apoptolidin C apart from our own.
10
  Due to the lack of information surrounding this natural 
product, and the structural complexity it possesses, we found apoptolidin C to be a high profile 
target to showcase the iterative application of our asymmetric acyl-halide aldehyde 
cyclocondensation reaction (AAC). 
 5 
2.0  PREVIOUS TOTAL SYNTHESES OF APOPTOLIDIN A 
 
To date there have been no total syntheses of apoptolidin C or its aglycone.  During our research 
we relied upon precedent from the syntheses of apoptolidin A, which maintains a high degree of 
structural homology with apoptolidin C.  In contrast apoptolidin A has been synthesized in its 
entirety three separate times by professors K. C. Nicolaou,
4,11-14
 Ulrich Koert,
15-19
 and most 
recently by Michael Crimmins.
20-22
  There have also been studies on the aglycone synthesis by 
Professor Gary Sulikowski,
23-26
 and extensive fragment syntheses by Professor William 
Roush,
27,28 
amongst others. 
2.1 PROFESSOR K. C. NICOLAOU’S SYNTHESIS 
Professor Nicolaou completed the first synthesis of apoptolidin A in 2001 utilizing a 
convergent approach to the aglycone.  His retrosynthetic approach was based upon dividing the 
core structure into two hemispheres, with the upper portion containing the unsaturated triene, 
along with two stereocenters, while the lower hemisphere containing only a single unsaturation 
which was used for a Stille cross-coupling, and the fully substituted c-bound glycoside (figure 2).  
Combining the two fragments using a Stille coupling, followed by a Yamaguchi 
 6 
macrolactonization is a very classical approach, and was utilized subsequently in other syntheses 
of apoptolidin A. 
 
 
Figure 2. Nicolaou’s Retrosynthetic Approach 
 
The C12-C28 fragment (3) was synthesized by coupling dithiane 4 to aldehyde 5.  This 
provided the unmasked dithiane after deprotection of the TBS groups, which spontaneously 
cyclized to the pyran moiety of the natural product.  Aldehyde 5 was synthesized from 
commercially available (+)-glycidol (6) using stoichiometric chiral reagents.   
Dithiane 4 originated from a similar chiral material, (-)-methylglycidol (Figure 3).  Ring 
opening of the epoxide with lithiodithiane, and subsequent reduction provided the PMB 
 7 
protected aldehyde 8.  Using Brown’s crotylation procedure on 8, followed by protection with 
TBS-OTf and oxidative cleavage using NaIO4 and OsO4 yielded the chiral aldehyde 7.
12
  
Subsequently a second crotylation was attempted, however it gave the wrong diastereomer of the 
product.  Employing Evans’ oxazolidinone technology, the authors were able to obtain the 
desired product.  After some functional group manipulations, they obtained the desired dithiane 4 
with the syn, anti, syn-arrangement of contiguous stereocenters. 
 
 
Figure 3. Nicolaou’s Dithiane Synthesis 
 
The construction of the three carbohydrate building blocks was accomplished by 
beginning with readily available L-rhamnose derived thioglycoside 10 to form sugars 12 
(Scheme 1), and 14 (scheme 2),  while sugar 16 was formed from thioglycoside 17.  In the 
forward direction, sugar 12 was synthesized by methylation of the C4 alcohol of thioglycoside 
10, followed by acetal deprotection, and selective C3 protection with a TBS group.  An 
oxidation/reduction sequence performed on alcohol 11 inverted the C2 stereochemistry to the all-
equitorial β-anomer 12. 
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Scheme 1: Nicolaou’s Saccharide Synthesis 
 
 
The disaccharide containing two C2 deoxy-sugars posed a particular challenge.  They 
began with thioglycoside 10, which after a series of protecting group manipulations, and one 
oxidation, gave ketone 13.  Treatment with methyl Grignard gave the correct diastereomer of the 
tertiary alcohol, presumably under chelate control to PMB ether.
12
  The remaining carbohydrate 
was synthesized very quickly from thioglycoside 17.  A few more functional group 
manipulations were required to formulate sugar 16 into its active coupling partner.  Once 
accomplished it was coupled with 15 using SnCl2, giving the complete disaccharide (19), after 
treatment of Raney Ni to remove both thiophenyl groups. 
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Scheme 2: Nicolaou’s Disaccharide Synthesis 
 
2.2 PROFESSOR ULRICH KOERT’S SYNTHESIS 
Professor Ulrich Koert completed the synthesis of apoptolidinone A in 2001,
17,19
 and followed 
that work by publishing the complete natural product in 2004.
15,16,18
  The initial disconnections in 
Koert’s synthesis are identical to those chosen by Nicolaou, including the sp2-sp2 coupling 
between C11 and C12, as well as the C1-O bond of the ester.  However, Koert chose to also make 
a disconnection between C15 and C16 (Figure 4).  He also chose to install the C19 and C20 hydroxy 
functionality via dihydroxylation following the cyclization of the furan ring.  The cyclized 
product gave a higher degree of diastereocontrol over the dihydroxylation than was demonstrated 
on both test substrates, as well as the uncyclized precursor 22.
18
  The α,β-unsaturated ketone was 
formed from a nucleophilic displacement of the amide (23) by a lithiated vinyl Iodide species 
 10 
that was comprised of C12 through C15.  The protected polypropionate chain (22) could then be 
deprotected with PPTS in MeOH to close the furan ring. 
 
 
Figure 4. Koert’s Retrosynthetic Approach to the C12-C28 Fragment 
 
Weinreb amide 23 was constructed in a very short linear sequence starting with methyl 4-
methyoxyacetoacetate (Scheme 3).  An asymmetric reduction provided ester 24, followed by a 
dibal reduction to provide aldehyde 25.  The β-keto imide building block 26 was added to give 
ketone 27 in 97% yield as a 96:4 diastereomeric ratio.  Anti-reduction of the ketone gave the 
desired syn, anti, syn-configuration of the propionate chain.  Finishing the sequence with a 
transamination followed by bis-TMS protection yielded amide 23.   Koert demonstrated an 
expedient asymmetric synthesis to a complex building block using mainly chiral auxiliaries, with 
a catalytic asymmetric reduction as the initial stereodefining step. 
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Scheme 3: Koert’s C21-C28 Synthesis 
 
a. Ru-(S)-Binap, H2, MeOH, DMF, 95 °C (86%, 97% ee); b. i)TBDMSCl, imidazole (95%); ii) 
iBu2AlH, hexane, (90%); c. 26, Sn(OTf)2, Et3N, CH2Cl2, (97%, 96:4 dr); d. Me4NBH(OAc)3, 
HOAc, CH3CN (74%, 95:5 dr); e. i) AlMe3Me(MeO)NH·HCl, HOAc, CH2Cl2 (81%); ii) 
TMSCl, imidazole (86%). 
 
Professor Koert and coworkers approached the three sugar residues with a similar 
strategy as was previously demonstrated by Nicolaou.  The C9 glycoside (glycoside A) was 
constructed in a very similar manner starting with the same L-rhamnose derivative.  Likewise, 
the C27 sugar (glycoside B) was constructed from the same chiral building block (figure 5). 
 
 
Figure 5. Koert’s Approach to Saccharides A and B. 
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The approach to the terminal residue of the disaccharide appended to C27 (glycoside C) 
bears a resemblance to the synthesis of glycoside B, and is quite concise (scheme 4).  Koert is 
able to use the C3-5 stereocenters from glucose in the unsaturated form of D-glucal to his 
advantage.  After differential funtionalization of the three alcohols in glucal to form 29, the 
trichloroacetimidate was formed at C1 after introduction of the C2 thiophenol substituent.  The 
syn-installation of the C1/C2 substituents allowed for selective β-formation of the glycosidic 
bond.  Using trimethylsilyl triflate as a lewis acid activator for the SN2 bond formation provided 
the complete disaccharide (30), which required two manipulations to form the coupling precursor 
31. 
 
Scheme 4: Koert’s Disaccharide Synthesis 
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2.3 PROFESSOR MICHAEL CRIMMINS’ SYNTHESIS 
Professor Crimmins completed the synthesis of aglycone of apoptolidin A in 2005,
20
 along with 
a separate publication on the synthesis of the three saccharide units.
22
  In 2009 he published the 
complete synthesis of apoptolidin A
21
 which combined the previous publications, and really 
showcased the versatility of his thiazolidinethione chiral auxiliary chemistry.
29
  Professor 
Crimmins published the first de-novo synthesis of apoptolidin A.  He was able to use chiral 
auxiliaries and stoichiometric chiral reagents to form the requisite stereocenters without having 
to use the chiral pool.  His overall strategy for the aglycone was very similar to that of Nicolaou 
and Koert.  After dividing the aglycone into a northern and southern hemisphere he used classic 
aldol type chemistry to form the polypropionate C21-C28 fragment.  It is in this fragment (34) that 
the iterative application of his chiral auxiliary chemistry can be seen. 
 
 
Figure 6. Professor Crimmins’ Retrosynthetic Approach 
 
 14 
Stereoselective alkylation of 35 (Scheme 5) followed by removal of the chiral auxiliary 
and subsequent aldol reaction with chiral thiazolidinethione 37 gave excellent stereocontrol in 
the assembly of alcohol 38 (90%, >98:2 syn).  Functional group manipulations led to a second 
aldol using the same chiral auxiliary as before, however with a reduced yield (62%).  Professor 
Crimmins’ approach led to a very efficient synthesis of the complex polypropionate 34 in few 
linear steps, however, it is plagued by functional group manipulations, use of super 
stoichiometric metal reagents, and the unmentioned syntheses of the chiral auxiliaries, which are 
not trivial. 
 
Scheme 5: Crimmins’ C20-C28 Synthesis 
 
a. i) NaN(SiMe3)2, PhMe, THF, H2C=CHCH2I (75%); ii) NaBH4, THF, H2O (85%); iii) NaH, 
MeI, THF (88%); iv) OsO4, NMO, THF, H2O; v) NaIO4, H2O, THF (60% for two steps); b. 37, 
TiCl4, (–)-sparteine, NMP, CH2Cl2, then 36 (90%); c. i) Et3SiOTf, 2,6-lutidine, CH2Cl2 (97%); 
ii) 
i
Bu2AlH, heptane, CH2Cl2 (86%); d. 37, TiCl4, 
i
Pr2NEt, CH2Cl2, then 39 (62%); e. i) Me3SiCl, 
Et3N, DMAP, CH2Cl2 (79%); ii) (MeO)2P(O)Me, n-BuLi, THF (96%). 
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It can be seen in the previous syntheses that the sugar residues provide one of the greatest 
challenges in the synthesis of apoptolidin.  The number of reactions required to complete a small 
synthetic fragment is disproportionately high.  Professor Crimmins took a different approach 
than previously seen in Nicolaou or Koert’s work.  The similarities between the three sugars in 
Crimmins’ work can be seen in figure 7.  All three sugars began with a similar chiral auxiliary 
which was alkylated, followed by appropriate functionalization, and eventual ring closure.  
Glycoside A is formed via a dihydroxylation of alkene 41, followed by silyl removal, and 
concurrent cyclization.  The approach to glycoside B is extremely similar, however the chiral 
auxiliary is removed by methyl Grignard addition to yield the methyl ketone 42.  A chelate 
controlled allylation with allyltributylstannane gives the correct diastereomer with >20:1 
selectivity, and nicely sets up an oxidative cleavage of the terminal alkene to form the glycoside 
upon acidic removal of the triethylsilyl protecting group.  The enantiomer of the starting material 
is used for the synthesis of glycoside C.  Arriving at aldehyde 43 provides the proper substrate 
for another chelate controlled allylation under similar conditions as before.  Again, a 
diastereoselectivity of >20:1 is seen, and the resulting alcohol is methylated, followed by 
functional group manipulation, and eventual closure to the saccharide. 
 
 16 
 
Figure 7. Crimmins’ Saccharide Synthesis 
2.4 PROFESSOR GARY SULIKOWSKI’S SYNTHESIS 
Professor Sulikowski took a different approach to the construction of the aglycone than did the 
three previous syntheses.  The primary disconnections were aimed at creating the shortest linear 
sequence, coupled with a highly modular approach.  In previous syntheses the pyran unit was 
pre-formed, however Sulikowski appended the C20-C28 fragment in a linear form, allowing 
cyclization upon global deprotection.   
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Figure 8. Professor Sulikowski’s Retrosynthetic Approach 
 
Triene 45 was synthesized starting from (S)-malic acid setting the C17 stereo center, 
followed by a chelate controlled grignard addition to set the hydroxyl group at C16, that was 
elaborated with a Suzuki-Miyaura coupling to install the upper portion of the triene.  Using a 
diastereoselective Mukaiyama aldol reaction aldehyde 45 was coupled with ketone 48 to give a 
50% yield of a 4:1 mixture of diastereomers.  Following the aldol, a Yamaguchi esterification 
appended 46 to the newly formed hydroxyl at C19.  The resulting compound was elaborated 
further via aldol addition with aldehyde 47 before being subjected to the metathasis and Suzuki-
Miyaura coupling to yield the macrolactone 44.  Sulikowski’s synthesis benefits from a highly 
modular approach, and therefore is an easily adaptable synthesis that has few long linear 
sequences, and allows for a rapid construction of analogs. 
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3.0  CATALYTIC ASYMMETRIC SYNTHESIS OF APOPTOLIDINONE C 
Polyacetate and polypropionate architecture is ubiquitous in naturally occurring compounds.
30
  
Due to their utility in assembling such structures, aldol-based reactions have dominated the field 
of polypropionate synthesis.
31
  Methods have historically been based upon stoichiometric chiral 
directors, either relying upon chiral reagents, or auxiliaries.  Many groups have been occupied 
with the development of catalytic asymmetric variants of aldol reactions, and to this end we have 
pursued the construction of aldol equivalents in the form of β-lactones, as building blocks for 
polypropionate synthesis.   
 Our group has developed two complimentary methods with which to form chiral 
β-lactones using either a Lewis basic (cinchona alkaloid), or Lewis acidic (chiral aluminum 
species) catalyst to affect the transformation from aldehyde to β-lactone (Figure 9).  Through the 
use of insitu generated substituted ketene from readily available acyl halides we can form either 
acetate, or propionate equivalents.  We have labeled this reaction the acyl-halide aldehyde 
cyclocondensation (AAC). 
 19 
 
Figure 9. Catalytic Asymmetric Aldol Equivalents. 
 
Apoptolidin A contains much of the same polypropionate architecture, and the efficiency 
of chiral auxiliaries has been well demonstrated on its core synthesis.
12,20
  We have viewed 
apoptolidin C as a platform from which to evaluate, and demonstrate the iterative application of 
our AAC technology for synthesizing complex polypropionate arrays.  The application of the 
AAC reaction follows an iterative sequence that is similar to the biosynthetic polyketide 
assembly.  The biosynthetic pathway contains three main steps in route to a polyketide array. 
(Figure 10)  The first step is elongation of the chain as it is transferred from the ketosynthase to 
the acyl carrier protein.  After elongation, there must be a functionalization step to attain the 
desired structural unit, followed by a transfer step, which allows for a subsequent elongation.  
 20 
 
Figure 10.  Biosynthetic Pathway for Polyketide Synthesis  
 
Using small molecule catalysis we can mimic the biological pathway for production of 
these complex units.  In our procedure we begin with an aldehyde which can undergo elongation 
in the first step (Figure 11).  In our process we must ring open the β-lactone and protect the free 
alcohol in order to propagate the chain, which also requires a reduction, as our third and final 
step. 
 21 
 
Figure 11. Small Molecule Catalysis Method for Polyketide Synthesis 
3.1 RETROSYNTHESIS OF APOPTOLIDIN C 
Our retrosynthetic analysis of apoptolidin C begins with the intention of stereocontrol 
being achieved solely through the use of catalytic asymmetric aldol reactions, notably our AAC 
technology.  We attempted to build flexibility directly into the synthesis by allowing many of the 
major fragment coupling sequences to occur in a number of different orders.  As an example of 
this flexibility, we required four major coupling reactions: two glycosidations, a Stille Coupling, 
and a Yamaguchi macrolactonization.  We envisioned that these four reactions could be carried 
out in any order once all the building blocks were in hand.  This allowed us to probe the most 
efficient construction of the aglycone, and subsequently the natural product, while limiting the 
number of revisions necessary to the individual building blocks.  We began by removing the 
three saccharides, providing a synthetic route to apoptolidinone C.  While building the aglycone, 
 22 
we hoped to draw upon the considerable knowledge available for the construction of apoptolidin 
A, so we chose the well developed C11-C12 disconnection, and the C19-O disconnection, using a 
Stille coupling, and Yamaguchi macrolactonization, respectively to provide compound 75.  
The synthesis of the C12-C28 fragment (75), and subsequent construction of the aglycone 
is the primary focus of this publication, followed by synthetic studies on the C9 saccharide.  Our 
approach to the C12-C28 fragment was a convergent design, hinging upon the use of AAC 
chemistry for the formation of six of the requisite eight stereocenters, the results of which are 
compounds 54, 61, 64, and 67.  We disconnected compound 75 via a methyl ketone aldol 
addition, which leads to two fragments, 58 and 69a, both of which can be constructed using 
AAC technology. 
 
 23 
 
Figure 12. Retrosynthetic Approach 
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3.2 SYNTHESIS OF THE C12-C19 FRAGMENT 
Known aldehyde 53 was prepared by a five step sequence beginning with the inexpensive and 
commercially available alcohol 49 (Scheme 6).
32
  Treating 49 with thionyl chloride gave 
compound 50 in 78%, which was treated with sodium amide in liquid ammonia to provide the 
terminal alkyne 51.
33
  Trimethylsilyl protection of the primary alcohol followed by methylation 
of the alkyne yielded alcohol 52 in a 63% yield over three steps.  Oxidation (PCC) of this 
primary alcohol gave very clean conversion to aldehyde 53, which was used in the following 
AAC chemistry to form the first stereocenter in this sequence. 
 
Scheme 6: Synthesis of Aldehyde 53
 
 
a. SOCl2, pyridine, CH2Cl2, 35 °C, 24 h (78%); b. Na, Fe(NO3)3, NH3, −33 °C, 3 h; c. TMSCl, 
imidazole, CH2Cl2, rt, 48 h; d nBuLi, MeI, THF, −78 °C - rt, 2 h (63% for 3 steps); e. PCC, 
CH2Cl2, 0 °C 3 h. 
 
In order to affect the AAC transformation of aldehyde 53 a second generation aluminum 
catalyst (59) gave the best yields, which was prepared in a published sequence from D-valine 
(Scheme 7).
34,35
  The active catalyst was generated in situ from the tri-amine precursor and 
Me2AlCl in CH2Cl2 at ambient temperature.  It should be noted however, the simpler first 
generation catalyst can be employed, albeit with slightly lower yields.  After generation of 
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ethenone from acetyl bromide, aldehyde 53 was added, and the resultant β-lactone was formed in 
51% yield over two steps (Scheme 7).  To ascertain a level of enantioselectivity in this 
cyclocondensation reaction, the β-lactone was ring opened with enantiomerically pure α-methyl 
benzylamine, to furnish the β-hydroxy amide.  Only a single diastereomer was formed within the 
limits of detection of NMR, giving a dr of >95:5. 
 
Scheme 7: Synthesis of C12-C19 Fragment
 
 
a. 59, Me2AlCl, 
i
Pr2NEt, acetyl bromide, CH2Cl2, −78 °C, 18 h (51% for 2 steps); b. N,O-
dimethylhydroxylamine hydrochloride, Me2AlCl, CH2Cl2, 0 °C to rt, 3 h (81%); c. R = Me: MeI, 
NaH, DMF, THF, 0 °C, 1 h (80%); R = PMB: PMBOC(NH)CCl3, 15 mol % BF3 Et2O, CH2Cl2 
(60% for 2 steps); d. 
i
Bu2AlH, THF, −78 °C, 2 h (97%). 
 
 
Ring opening of the β-lactone (54) with N,O-dimethylhydroxyl amine activated by 
Me2AlCl gave the β-hydroxy amide.  Upon subsequent methylation the β-methoxy amide 55 was 
obtained in good yield (80%).  As will be seen later in the synthesis, the analogous product 
containing a PMB ether in place of the methyl ether (56) was required for diastereocontrol of the 
subsequent aldol reaction (vide infra).  Compound 56 was prepared using the p-methoxybenzyl 
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trichloroacetimidate and boron trifluoride in methylene chloride.  Reduction of the Weinreb 
amide to the aldehyde was accomplished in excellent yield (97%), to provide 58, while the yield 
for the reduction of 55 to 57 could not be ascertained due to the instability of the resulting 
aldehyde. 
3.3 SYNTHESIS OF THE C20-C28 FRAGMENT 
Ketone 69 is characterized by a syn,anti,syn-relationship of four contiguous stereocenters, as 
well as a 1,3-anti relationship between C25 and C27 (Scheme 9).  In the previous syntheses of this 
portion of apoptolidin A, a number of strategies have been employed, many of which rely on the 
use of stoichiometric chiral auxiliaries for the installation of the requisite chirality.  We chose to 
avoid the use of chiral auxiliaries and synthesize the fragment from achiral starting materials 
implementing an iterative application of our AAC technology to demonstrate how efficient and 
selective the AAC methodology is. 
 
Scheme 8: Synthesis of β-Lactone 64 
 
a. 65, Me2AlCl, 
i
Pr2NEt, acetyl bromide, CH2Cl2, −50 °C, 12 h (81%); b. N,O-
dimethylhydroxylamine hydrochloride, Me2AlCl, CH2Cl2, −35 °C, 12 h (81%); c. TBSOTf, 2,6-
lutidine, CH2Cl2, −60 °C, 12 h (99%); d. 
i
Bu2AlH, THF, −78 °C, 2 h (95%); e. TMS-Qd, 
i
Pr2NEt, 
LiClO4, propionyl chloride, CH2Cl2/Et2O, −78 °C, 18 h (78%). 
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Starting with methoxyacetaldehyde (60), prepared from the published procedure using 3-
methoxy 1,2-propanediol,
36
 the Al-catalyzed AAC reaction was carried out (Scheme 8) with the 
first generation triamine ligand (65) in 81% yield.
34,37
  The enantiomeric excess of 61 was 
established by ring opening with a chiral amine, and analyzed by NMR spectroscopy.  The 
product amide was a single diastereomer within the limits of detection, giving an ee of the β-
lactone of greater than 95%.  In preparing the aldehyde for the next AAC, the β-lactone was 
opened with N,O-dimethylhydroxyl amine, and the alcohol immediately protected as a TBS ether 
in 80% yield over the two steps.  Reduction of amide 62 with DIBAL proceeded without 
complication to provide aldehyde 63 in 95% yield.   
Following the synthesis of aldehyde 63 we required a second sequential AAC reaction in 
order to install the C24 and C25 methyl, and hydroxyl group.  This iteration of our AAC chemistry 
demanded the use of propionyl chloride, providing methylketene in solution, and subsequently 
yielding a di-substituted β-lactone (64).  The use of methylketene to form polypropionate arrays 
often has higher enantiomeric excess when using the Lewis-basic conditions instead of the 
previously seen aluminum catalysts.
38,39
  Therefore, the two remaining β-lactones were formed 
under the cinchona alkaloid conditions (Scheme 9).  Unfortunately the AAC reaction of aldehyde 
63 under our standard set of conditions
38
 (developed for α-unsubstituted aldehydes) gave only 
small amounts of β-lactone 64 while providing a large amount of ketene dimer as a byproduct.   
Previous studies have shown that AAC reactions on α-chiral aldehydes proceed with a 
high degree of reliability and predictability,
40
 and in early studies β-branched substrates gave 
similar results to unbranched aldehydes.  AAC reactions had not been carried out on chiral β-
substituted aldehydes until the synthesis of  pironetin (figure 13).
40,41
  In the pironetin example, 
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the aldehyde (a β-alkoxy aldehyde with a large protecting group) was unreactive toward 
cinchona alkaloid catalysis, and the aluminum catalyzed reactions were employed with a 20% 
catalyst loading to afford 25% yield of the desired product.  An increase in catalyst loading to 
50% provided a usable amount of product (65% yield) with excellent diastereoselectivity.  It 
should be noted that the ketene precursor used in this example is butyryl bromide, thus providing 
ethyl ketene.  The difficulties in accessing high conversion to the AAC product through cinchona 
alkaloid catalysis may have been due to the added steric bulk of the ethyl group.  
 
 
Figure 13. Pironetin’s Final AAC Step 
 
In order to optimize the cinchona alkaloid catalyzed version of our AAC methodology a 
number of standard variables were probed such as temperature, concentration, equivalents of 
ketene precursor, and reaction time.  Modifying the Lewis acid used (MgCl2, LiClO4, LiI, 
ranging from 0.5-2.0 equiv), or increasing the cinchona alkaloid catalyst loading gave no benefit, 
and the competing pathway of ketene dimerization continued to be a significant problem.  This 
was addressed with a much slower addition of propionyl chloride (from 1h to 4h with a 10:1 
dilution in DCM).  The slow addition of ketene precursor allowed for a very small concentration 
of ketene to be present in solution at any given point, which allowed for a reduction in the rate of 
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dimerization relative to cycloaddition.  With this modification were able to isolate the desired β-
lactone (64) in a very good yield (78%) and as a single diastereomer.  
 
Scheme 9: Synthesis of C20-C28 Fragment 
 
a. N,O-Dimethylhydroxylamine hydrochloride, Me2AlCl, CH2Cl2, −45 °C, 12 h (68%); b. 
TESOTf, 2,6-lutidine, CH2Cl2, −60 °C, 2 h (90%); c. 
i
Bu2AlH, THF, −78 °C, 3 h (95%); d.  
TMS-Qn, 
i
Pr2NEt, LiI, propionyl chloride, CH2Cl2/Et2O, −78 °C, 18 h (77%); e. N,O-
dimethylhydroxylamine hydrochloride, Me2AlCl, CH2Cl2, −45 °C, 12 h (99% combined yield); f. 
TESOTf, 2,6-lutidine, CH2Cl2, −60 °C, 3 h (88%); g. MeMgBr, THF, 0 °C, 3 h (78%). 
 
Continuation of the synthesis required converting β-lactone 64 to aldehyde 66 in order to 
perform the next AAC reaction.  For the synthesis of 66 from β-lactone 64 we employed a 
standard sequence of N,O-dimethylhydroxyl amine ring opening, protection, and amide 
reduction with 
i
Bu2AlH to yield aldehyde 66 in 58% yield over the three steps.  The final AAC 
reaction in this sequence provided a good yield of β-lactone 67 (77% of a single diastereomer). 
The third iteration of our AAC reaction uses as its substrate, an α-chiral aldehyde, and 
therefore, the stereocontrol requires more analysis, and is no longer only under catalyst control.
41
  
In the absence of substrate chirality prediction of the outcome of the cyclocondensation can be 
achieved using established stereochemical models.
40,42
  To predict the outcome of α-chiral 
aldehyde aldol reactions both the reagent and substrate chirality must be accounted for.   
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The analysis begins with the addition of the cinchona alkaloid into the ketene, and the 
favored Z-enolate
43
 is formed due to a minimization of A
1,3
 strain between the methyl and 
cinchona alkaloid groups.  The Zimmerman-Traxler model is oriented in an anti-Felkin/Ahn type 
approach to avoid the destabilizing syn-pentane interaction (Figure 14).
42
  The desired syn, anti, 
syn-aldol outcome is the matched case in which the reagent stereochemistry and the catalyst 
control are reinforcing, and is formed in very high diastereomeric ratios. 
 
 
Figure 14. Double Diastereoselective AAC reactions. 
 
Compound 67 was formed from three sequential AAC reactions using both Lewis acid 
and base catalysis with absolute control over all five stereocenters.  Ring opening of the final β-
lactone (67, Scheme 9) using N,O-dimethylhydroxyl amine gave two products, the desired mono 
alcohol, as well as a diol resulting from the TES-deprotection of the product in a combined yield 
of 99%.  Both products were subjected to the same TESOTf protection, providing 88% of the 
bis-TES protected amide.  Treatment with MeMgBr gave the desired methyl ketone 69 in 78% 
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yield.  The completion of the methyl ketone (69) gave us the requisite materials to probe the 
aldol coupling. 
3.4 ALDOL COUPLING OF AGLYCONE FRAGMENTS 58 AND 69 
Aldol additions of methyl ketones are often unpredictable in their stereochemical outcome, and 
thus have rarely seen use in late stage synthetic applications.  Recent studies have shed some 
light on one of the root causes for this unpredictability, 
44
 namely the tendency for boron enolates 
to occupy a boat transition state, instead of the more commonly seen chair transition state of the 
Zimmerman-Traxler model. A major obstacle in the synthesis of apoptolidinone C was the 
stereoselective C19-C20 bond formation.  Initial attempts to join the two fragments together 
provided the desired product (72) as the minor component of a mixture of diastereomers at C19.  
In order to achieve good stereocontrol over the aldol reaction an extensive review of the 
literature yielded a number of possible stereoinduction methods that may be playing a role in the 
aldol reaction shown below.  A clear understanding of the factors that control the transition state 
of these methyl ketone aldol additions should provide a path to the optimal conditions to achieve 
the desired results.   
 
 
Figure 15. Aldol Reaction for the Formation of Ketone 72 
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The following table is a summary of the major modes of stereoinduction in methyl ketone 
aldol additions, and a more detailed analysis of each model follows the tabular data.  Table 2 
shows four modes of simple stereoinduction (entries a-d), as well as doublesteredifferentiating 
reactions (entries e-h) which use two of the simple modes of induction together.  Some of these 
modes of induction rely upon closed or open transition states, which is noted under the 
“induction type” column, while others rely upon particular choices of protecting group. 
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Table 2.  Asymmetric Induction Effects for Methyl Ketone Aldol Additions. 
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3.4.1 1,2-Stereoinduction 
The aldehydes relevant to the synthesis of apoptolidin C (Figure 15, 57 and 58) don’t contain an  
α-stereocenter, however a discussion of stereoinduction that omits this ubiquitous method would 
be incomplete.  The effect of a stereocenter adjacent to the aldyhyde has been studied extensively 
with respect to attack of various nucleophiles.
45-47
  The accepted transition state model follows 
“Felkin” selectivity, and is described via transition state structures A and B (Figure 16).  When 
using a non-chelating Lewis acid (BF3·Et2O), this reaction takes place through an open transition 
state. 
 
 
Figure 16. Transition State Describing 1,2 Stereocontrol. 
 
1,2 induction of aldol stereochemistry is well precedented, and generally imparts high 
selectivity.
48
  Using Felkin models to predict the outcome of 1,2 induction is illustrated in Table 
2 (entry a), and is generally anti. 
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3.4.2 1,3-Stereoinduction 
Prediction of product geometry based on reagent stereochemistry and choice of metal for either 
chelate, or non-chelate control in β-alkoxy aldehydes has been known since the early 1950’s.49-51  
A revised transition state structure, was proposed in 1996
48
 where the alkoxy substituent is 
aligned anti to the carbonyl group to minimize dipole interactions.  The dominant steric 
interaction in the revised model (Figure 17) is the R group of the chain eclipsing the carbonyl 
oxygen (C).  In the other accessible transition structure, the less sterically bulky hydrogen 
occupies that site (D), which leads to the preferred 1,3-anti product, as can be seen in example b 
in Table 2. 
 
 
Figure 17. Transition State Model for 1,3 Stereocontrol. 
 
The presence of 1,3 induction as seen above is attained when the system is in an “open” 
transition state.  This is best exemplified in the Mukaiyama aldol reaction where M=TMS, and 
using a mono-dentate lewis acid, such as BF3•Et2O.  The use of Bu2BOTf to form a chelate 
between the aldehyde and enolate do not show 1,3 induction of stereochemistry.
44
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Alternatively, a widely accepted chelate based model has been proposed that coordinates 
the aldehyde oxygen with the β-alkoxy substituent to form a rigid six-membered ring capable of 
directing facial approach of a nucleophile.
51,52
  However it is noted that the group that caps the 
alkoxy substituent plays a significant role in the ordered structure of the transition state.
50
  When 
sterically bulky groups occupy the oxygen, a rigid transition state is formed placing the large 
bulky group in a pseudo equatorial position.  However, with a small protecting group, there is 
ambiguity in the transition state, leading to significantly lower diastereoselectivities, notably 
when the β-alkoxy group is capped with CH3.
50
 
3.4.3 1,4-Stereoinduction 
Recent computational studies have shown very low energy differences between the boat and 
chair conformations of unsubstituted enolate additions, when chelating lewis acids are used, such 
as dibutyl boron triflate.
53
  It is their assertion that the minimal energy difference could erode 
selectivity in many 1,4 induction reactions, however, many such reactions see a strong 1,4 syn 
dependence.   
In boron mediated aldol reactions where a chiral substituent is alpha to the ketone, there 
can be a strong preference to form the 1,4-syn product
54-56
 seen in example c in Table 2.  This 
preference has been explained via a formyl hydrogen-bonding model,
56
 and has been borne out 
experimentally.  The proposed hydrogen-bonding transition state is very similar to that of the 1,5 
induction model (Figure 18).  It must be pointed out that this induction affect is only noticeable 
in boron mediated processes, and the affect is negligible in open transition-state processes. 
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3.4.4 1,5-Stereoinduction 
The prediction of stereo induction from an alkoxy substituent at the beta position to the enolate is 
illustrated in example d of Table 2.  Recently, Goodman and coworkers proposed a transition 
state structure that explains levels of 1,5-anti induction previously seen.
56
  The analysis 
compared the relative energies of transition state structures for a number of chair and boat 
conformations for simple unsubstituted aldol reactions, as well as alpha and beta substituted 
ketones.
53
  The explanation given for 1,5-anti induction is one of hydrogen-bond stabilization, 
which they also used successfully to predict the 1,4-syn induction.  Based on computational 
calculations the 1,5-anti configuration (Figure 18) is lower in energy than the 1,5-syn 
conformation due to the steric interaction imparted by the R` group and the ligands on boron.  
This affect, as in the 1,4 induction, is only observed in boron mediated aldol reactions.  
The formyl hydrogen-bonding models also coincide nicely with an observation made by 
both Evans
44
 and Dias
57
 concerning protecting groups on the β-alkoxy group.  High levels of 1,5 
control are consistent throughout a wide range of protecting groups that allow hydrogen bonding, 
such as a 1,3 diol acetonide, PMB ether, OBn, and PMP acetal.  Accordingly, when a protecting 
group that blocks chelation, such as TBS is employed, the diastereocontrol is substantially 
eroded. 
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Figure 18. Transition State Model for 1,5-Anti Induction. 
 
3.4.5 1,4- and 1,5-Double stereodifferentiating reactions 
When attempting to control the stereochemistry of an aldol reaction employing an α-methyl, β-
alkoxy methylketone the two chiral centers may be reinforcing, or opposed, in their control of 
the developing alcohol stereocenter, table 2 (entry e).  Experimental observations have shown 
that when these two factors are competing against one another, the 1,5 induction will override 
the 1,4 induction as long as the protecting group of the β-alkoxy substituent meets the 
requirement of the simple 1,5 induction case, as stated above.
44,53,57
  If those requirements are not 
met, and a silyl protecting group, for example, is used, all diastereoselectivity is eroded.
57
 
Therefore careful consideration of protecting groups is important. 
3.4.6 1,3- and 1,5-Double stereodifferentiating reactions 
Stereocontrol in complex aldol couplings with both 1,3 and 1,5 alkoxy substituents can be 
simplified considerably with the choice of protecting group and lewis acid.  This is exemplified 
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in a series of aldol reactions published by Evans in 2003.
44
  When 1,5 anti-induction is desired, 
the protecting group must be chosen appropriately to allow for coordination to achieve high 
levels of stereoinduction.  However, if a silyl group is occupying the beta oxygen, and 1,3 
induction is desired based on an open transition state, very poor selectivities are generally seen.  
When using chelating conditions, the complexity of the transition state increases dramatically 
with increased substrate complexity, and the simple stereoinduction models presented here fail to 
accurately predict the outcome. Strong diastereocontrol is more easily predicted when using open 
transition states, as the 1,5 induction can be ignored. 
 
Scheme 10: Initial Methyl-Ketone Aldol Coupling 
 
 
The aldol reaction between ketone 69 and aldehyde 57/58 (scheme 10) using Bu2BOTf is 
predicted to have little, to no diastereocontrol.  The use of a boron enolate negates any 1,3 
control due to a closed transition state, where the stereocenters on the ketone side influence the 
outcome, and a silyl protecting group on the C23 oxygen deters any hydrogen bonding of the 
formyl hydrogen to that oxygen.  This potential lack of hydrogen bonding capability excludes 1,4 
as well as 1,5 control.  However, treatment of ketone 69 with Bu2BOTf and 
i
Pr2NEt, in Et2O 
followed by aldehyde 57 gave a 4:1 mixture of diastereomers.   
Attempting to determine the stereochemistry of the major diastereomer, an analysis of the 
resultant alcohol was performed by O-methylmandelate ester formation.
49
  The major 
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diastereomer was treated with both enantiomers of α-methoxy phenylacetic acid.  When 
comparing the 
1
H NMR spectrum of the two diastereotopic esters (70 and 71, Figure 19), the 
stereochemistry of the alcohol can be determined by noting which set of protons is shifted 
downfield relative to the diastereomer.  The protons of both products were unequivocally 
assigned based on 
1
H and COSY NMR analysis.  The shift is influenced by the proximity of the 
phenyl ring of the ester, and the conformation in solution of the structure.  The analysis shown in 
Figure 18 is the accepted solution state analysis, as the fisher projection is shown in an 
“extended” view down the length of the ester.  The methoxy group is oriented anti to the Csp2-O 
single bond of the ester, to minimize dipoles.  The phenyl ring shields the neighboring protons, 
shifting them upfield relative to the same protons on the diastereomer of the product.  This 
analysis led us to the conclusion that the (R) form of the stereocenter is the major diastereomer, 
which is the un-desired product. 
 
 
Figure 19. Stereochemical Analysis of the Aldol Product. 
 41 
 
In order to gain better control over the selectivity of the aldol transformation, a change in 
reagents was employed.  Treatment of the ketone with TMSCl, and NaHMDS gave only the 
kinetic enolate,
58
 which upon addition to the aldehyde with BF3•Et2O gave a 1:1 mixture of 
diastereomers.  The result was disheartening, because analysis of the sterechemical factors would 
suggest that the only control element in an open transition state of this system should be the 1,3 
influence of the β-alkoxy group.  Using a mono-dentate lewis acid such as BF3•Et2O, the only 
requirement for control is an anti arrangement of the carbonyl and alkoxy bonds to minimize the 
dipoles in the transition state and the orientation should not be highly dependant upon the 
protecting group on oxygen.  However, based on Keck’s work a chelate controlled addition 
where the oxygen substituent is a methyl group provides little to no stereochemical bias. 
A slightly electron donating protecting group, such as an alkyl methyl group would be 
just as strong of a directing group as a PMB ether.  A very common β-alkoxy substituent seen in 
many diastereoselectivity studies is a PMB ether, and therefore we chose this as a suitable 
protecting group to probe the Mukaiyama aldol reaction between the silyl enol ether derived 
from ketone 69 and aldehyde 58.   Table 3 summarizes the results of various attempts at coupling 
the two halves of the southern hemisphere of the aglycone, and resulted in the product being 
formed in good yield as a single diastereomer within the limits of detection of NMR. 
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Table 3. Summary of Results. 
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3.5 COMPLETION OF THE AGLYCONE 
With the aldol product (72, Scheme 11) in hand, we began the final steps to prepare the 
southern hemisphere of apoptolidinone for coupling.  The aldol product (72, Scheme 11) was 
treated with PPTS in a 1:1 mixture of CH2Cl2/MeOH, for 12 h at ambient temperature to 
selectively deprotect the two triethylsilyl groups while retaining the TBS alcohol.  Upon 
deprotection, the free C25 alcohol cyclyized onto the ketone to form the desired methoxy ketal 
(73).  Protecting the two free alcohols with TESOTf and 2,6-lutidine gave an excellent yield 
(98%) of the fully protected furan (74).  Precedent from the aglycone synthesis done by Nicolaou 
and coworkers provided the procedure for the hydrozirconation/iodination of the internal alkyne 
with three equivalences of Schwartz’s reagent in THF at 55 °C.  Due to the expected instability 
of the vinyl iodide (75) the product was not rigorously purified or characterized. 
The final fragment coupling leading to apoptolidinone C joined the complete upper (76 
Scheme 12) and lower (75) fragments via a Stille coupling utilizing the acetonitrile adduct of 
PdCl2 providing the E,E diene, as the major component of a 12:1 mixture in 75% yield.  Of key 
importance to the success of this reaction was the use of tetrabutylammonium 
diphenylphosphinate as a tin-halide scavenger.
59
  Coupling attempts without this salt resulted in 
an irreproducible mixture of diene isomers, often as a 1:1 mixture.
60
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Scheme 11: Completion of the Lower Half  
 
a. i) PPTS, MeOH/CH2Cl2 1:1, rt, 12 h (75%); ii) TESOTf, 2,6-lutidine, CH2Cl2, −55 °C, 3 h 
(98%); b. i) DDQ, 2:1 CH2Cl2:pH7 phosphate buffer; ii) Me3OBF4, proton sponge, CH2Cl2; c. 
Cp2ZrHCl, THF, 55 °C, 1 h, then I2, −20 °C. 
  
The successful Stille coupling was followed by a LiOH saponification, which yielded a 
mixture of products resulting from the partial deprotection of both TES protecting groups at the 
C19 and C23 alkoxy groups.  In order to simplify the mixture, the crude product was treated with 
trifluoroacetic acid to complete the deprotection, yielding the seco-acid in 48% yield over two 
steps.  Following the precedent set by previous syntheses of apoptolidinone A, we used standard 
Yamaguchi macrolactonization conditions, followed by a global deprotection with an acidic 
fluoride source: H2SiF6, yielding the completed aglycone in 57%, and 64% for the final two 
steps. 
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Scheme 12: Synthesis of Apoptolidinone C 
 
a. Pd2Cl2(MeCN)2, Ph2PO2NBu4, DMF, rt (73%); b. i) LiOH, THF, MeOH, H2O, rt; ii) 
CF3CO2H, CH2Cl2/MeOH, −15 °C (48% for 2 steps); iii) 2,4,6-trichlorobenzoyl chloride, NEt3, 
DMAP, THF, rt (57%); iv) H2SiF6, THF, MeCN, −35 °C, 48 h (64%). 
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4.0  CATALYTIC ASYMMETRIC SYNTHESIS OF THE C9 SACCHARIDE, AND 
EFFORTS TOWARDS THE COMPLETION OF APOPTOLIDIN C 
4.1 EARLY ATTEMPTS TO SYNTHESIZE THE C9 SACCHARIDE 
The completion of the aglycone gave us the opportunity to focus on the de-novo synthesis of the 
three saccharides appended to the aglycone, and finish the synthesis of the natural product.  Our 
goal was to generate the three sugars without the use of chiral auxiliaries, or stoichiometric chiral 
reagents.  My efforts were focused on the synthesis of the C9 sugar, 6-deoxy-4-O-methyl-L-
glucose (79). 
 
 
Figure 20. First Retrosynthetic Approach to Glycoside A. 
 
Our first approach to the synthesis of compound 79 was ambitious in its use of new, 
untested chemistry.  We planned on a ring closing reaction from the linear aldehyde 80, which 
we believed could be formed from one of two methods: 1. the chelate controlled allylation of 
aldehyde 81; 2. the Wittig homologation of the aldehyde followed by an asymmetric 
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dihydroxylation as seen in professor Crimmins’ work.22  These reactions were predicated upon 
the formation of the substituted butanaldehyde 81.  Our attempts at synthesizing the sugar 
became a study in merely synthesizing this α,β-alkoxy aldehyde with correct diastereoselectivity, 
and high enantiomeric excess.   
 We saw an opportunity to use our groups AAC chemistry to form the first 
stereocenter in the form of β-lactone 82,61 which, under the right conditions can be alkylated to 
give the anti-diastereoselectivity that we desired.
62,63
  We hoped to translate this behavior to an 
oxidative reagent such as Davis’ oxaziradine.64  In this manner we could assemble the α,β-anti-
stereochemistry that we desired in two simple steps that we predicted would be highly 
diastereoselective.  Unfortunately the α-oxidation product was unattainable under a variety of 
conditions, and although this would be an excellent reaction to develop, not only for the 
synthesis at hand, we decided to abandon that route in favor of more reliable chemistry. 
 
 
Figure 21. Second Retrosynthetic Approach Utilizing MacMillan’s Chemistry. 
 
Our second attempt at installing the correct stereochemistry was through an 
organocatalytic dimerization of silyloxy acetaldehyde (86).
65-67
  The proline catalyzed 
dimerization gives the aldehyde 85, which when treated with silylenol ether 84 under magnesium 
chelate conditions can give 83 as the major compound.
66
  This procedure fulfilled our 
requirements, by being a short, precedented route to the basic sugar form, using a chiral catalyst 
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to set the stereochemistry, and initially we were optimistic about the prospects that this chemistry 
presented.  Unfortunately, upon further experimentation we ran into major problems.  Firstly, the 
formation of aldehyde 86 was low yielding, and difficult to perform on large scale.  The dimer 
product was made in 4:1 diastereomeric ratio, which was only partially separable, and in a much 
lower yield than reported in the literature.  The combination of these facts left us with the need to 
carry out these reactions on extremely large scale, only to have a few grams of usable product.  
Following the dimerization, the chelate controlled aldol with 84 gave an approximately 10:1 
mixture of diastereomers, providing an inseperable mixture of four compounds.  Those four 
compounds then spontaneously cyclized creating another 1:1 anomeric mixture of each product 
(Figure 22).  The practicality of the synthesis was already being tested, before we approached 
any of the unknown chemistry. 
 
 
Figure 22. Details of Diasteriomeric Ratio Problems. 
 
A major problem with this route was the inability to separate the diastereomers from each 
other when run on a large scale.  Due to this, we were forced to carry mixtures through the 
synthesis, and ultimately were left with an unidentifiable mix of hydroxylated compounds.  
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Secondly, we had envisioned a late stage methylation of the C4 oxygen, after deprotection, and 
deoxygenation of the C5 primary alcohol.  The published routes to this sugar show an early 
installation of this methyl group.  During our attempts we noticed a concerning lack of stability 
when the C4 oxygen is deprotonated.  We attributed this to potential retro-aldol reaction, and 
attempted various procedures to circumvent the complete deprotonation, which improved the 
process slightly.  This route ultimately proved to be impractical, and we were therefore forced to 
abandon it in favor of a more traditional approach. 
4.2 COMPLETION OF THE C9 SACCHARIDE 
In our final approach we intended to install the methoxy substituent at an early stage, avoid the 
costly deoxygenation procedures that were necessary in the dimerization route, and use the 
substrate to control all of the stereodefining steps.  To this end we envisioned setting the three 
contiguous syn,syn stereocenters in 90 via a chelate controlled allylation.
68
  The strong precedent 
of this step gave us confidence that our approach would ultimately be successful.   
 
 
Figure 23. Final Retrosynthetic Approach to Glycoside A. 
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Following this, we would oxidativly cleave the alkene, and use a directed reduction to 
install the fourth stereocenter (88).  From the protected aldehyde, only an acidic deprotection, 
and functional group manipulation would remain. 
 
Scheme 13: Synthesis of the C9 Saccharide 
 
a. i) NaNO3, H2SO4; ii) TBSCl, imidazole; iii) BnOC(NH)CCl3, triflic acid; iv) 
i
Bu2AlH b. 
MgBr2
.
Et2O, (Z)-tributyl(3-methoxy-2-methylallyl)stannane (92), 0 °C c. i) TESOTf, 2,6-
lutidine, CH2Cl2; ii) O3, DMS; (d) i) Zn(BH4)2 ii) PPTS, CH2Cl2:MeOH e. i) dimethoxypropane, 
PPTS, CH2Cl2; ii) Bu4NF; iii) DMP, NaHCO3, CH2Cl2; f. HCl, THF, H2O; g. i) H2, 20% Pd/C;  
ii) PhSH, TfOH, THF, iii) TBSOTf, 2,6-lutidine. 
 
We began with a known route from serine to aldehyde 91 as seen in Mukaiyama’s 
synthesis of taxol.
69
 A chelate controlled allylation with 90 gave a 3:1 mixture of diastereomers, 
which were seperable by column chromatography, giving a 63% yield of a single product.   Silyl 
protection of the resultant secondary alcohol, and chelate controlled reduction of the ketone with 
Zn(BH4)2 (95%) gave us the desired syn,syn,anti arrangement of stereocenters we desired. 
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Scheme 14: Initial Tin Allylation Procedure 
 
 
We initially envisioned an allylation with the known allyl tin species 96, and this gave us 
excellent control of the desired alcohol.  After oxidative cleavage any attempt to selectively 
alkylate the aldehyde was met with a mixture of diastereomers, never better than 1.2:1.  In 
contrast, the route we chose to pursue utilized a directed reduction seen in scheme 13 (step d) 
which proceeded with absolute control, and a modified allylation reagent (92), which gave 3:1 
mixture of diastereomers, which were seperable by column chromatography, and was high 
yielding.   
Selective TES deprotection in the presence of the primary TBS group was achieved in 
good yield (79%), and the diol was protected with 2,2 dimethoxypropane using PPTS in 93% 
yield.  After removal of the primary TBS group with TBAF (89%), a DMP oxidation gave the 
aldehyde, which was treated crude with 1M HCl in a mixture of THF and H2O to yield 95 as a 
1:1 mixture of anomers.   
 We originally envisioned a thioglycosidation prior to the benzyl deprotection, in 
order to reduce the polarity of any intermediates, and ease any handling of the compounds, 
however this proved to be difficult.  The initial thioglycosidation proceded under standard 
conditions (PhSH, TfOH, r.t.), however all attempts at hydrogenolysis of the benzyl group gave 
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no reaction.  To circumvent this problem, we removed the benzyl group first, under standard 
palladium/H2 conditions, and without purification of the intervening triol formed the 
thioglycoside under triflic acid conditions.  The resulting thioglycoside was formed as a single 
anomer, which was later identified as the α-anomer.  A bis-TBS protection of the diol gave the 
known thioglycoside whose NMR spectrum was correlated to the same product as made by both 
Professor Crimmins, and Nicolaou. 
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5.0  SUPPORTING INFORMATION 
General Information:  Optical rotations were measured on a Perkin-Elmer 241 digital 
polarimeter with a sodium lamp at ambient temperature and are reported as follows: [α]λ (c 
g/100mL).  Infrared spectra were recorded on a Nicolet Avatar 360 FT-IR spectrometer.  NMR 
spectra were recorded on a Bruker Avance-300 (300MHz) spectrometer, or a Bruker Avance 500 
(500 MHz) with chemical shifts reported relative to residual CHCl3 (7.26 ppm) for 
1
H and CDCl3 
(77.0 ppm) for 
13
C NMR spectra.   
 Unless otherwise stated, all reactions were carried out in dry glassware under a 
nitrogen atmosphere using standard inert atmosphere techniques for the manipulation of solvents 
and reagents.  Anhydrous solvents (CH2Cl2, THF, DMF, diethyl ether, pentane and toluene) were 
obtained by passage through successive alumina and Q5 reactant-packed columns on a solvent 
purification system.  N,N-Diisopropylethylamine, and triethylamine were distilled under nitrogen 
from CaH2.  Dimethylaluminum chloride (1.0M in hexane) was purchased from Aldrich in 
Sure/Seal™ bottles.  Anhydrous LiClO4 (ReagentPlus) and LiI were purchased from Aldrich.  O-
trimethylsilyl quinidine (TMS-Qd) and O-trimethylsilyl quinine (TMS-Qn) was prepared 
according to the literature procedure.
38
  Commercially available acetyl bromide, propionyl 
chloride were redistilled under N2.  Flash chromatography was performed on EM silical gel 60 
(230-240 mesh). 
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 (R)-4-(Methoxymethyl)oxetan-2-one (61):  To a 0 °C solution of 0.866 g of 
amine catalyst (65) (1.60 mmol, 0.1 equiv) in 190 mL of CH2Cl2 was slowly 
added 1.60 mL of Me2AlCl (1.60 mmol, 1.0 M solution in hexane).  This homogeneous mixture 
was removed from the ice bath and stirred at ambient temperature for 1 hr before being cooled to 
−60 °C.  To this was added 4.74 mL of iPr2NEt (27.2 mmol, 1.7 equiv) followed by a dropwise 
addition of 2.25 mL of acetyl bromide (30.4 mmol, 1.9 equiv) over a period of 60 seconds.  The 
resulting yellow solution was stirred exactly 120 seconds while maintaining −60 °C whereupon a 
solution of 1.18 g of methoxyacetaldehyde (16.0 mmol, 1.0 equiv) in approximately 10 mL 
CH2Cl2  was added dropwise.  The reaction was maintained at −60 °C for 12 h.  Saturated 
aqueous NH4Cl (300 mL) was added and the mixture was extracted with CH2Cl2 (3 x 300 mL).  
The combined organic extracts were dried (MgSO4), and concentrated.  The resulting crude oil 
was purified by flash chromatography (40% EtOAc/hexanes on silica gel) to afford 1.69 g (91%) 
of the title compound as a clear colorless oil.  [α]22
D
  −32.9 (c 1.68, CHCl3). IR (thin film): 1830, 
1455, 1112, 827 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 4.67-4.62 (m, 1H), 3.74 (dd, J = 11.4, 3.0 
Hz, 1H), 3.64 (dd, J = 11.7, 4.5 Hz, 1H), 3.47 (dd, J = 16.2, 6.0 Hz, 1H), 3.44 (s, 3H), 3.39 (dd, J 
= 16.2, 4.5 Hz, 1H); 
13
C NMR (75 MHz, CDCl3) δ 168.2, 72.5, 69.9, 60.2, 40.2; HRMS (EI) m/z 
calcd for C5H8O3 (M)
+
: 116.0473; found: 116.0475. 
 
 (R)-3-Hydroxy-N,4-dimethoxy-N-methylbutanamide:  To a 0 °C 
solution of 3.08 g of N,O-dimethylhydroxylamine hydrochloride (31.6 
mmol, 2.0 equiv) in 50 mL of CH2Cl2 was added 31.6 mL of 
dimethylaluminum chloride (31.6 mmol of 1 M hexanes solution, 2.0 equiv).  The resulting 
solution was removed from the ice bath following the addition and allowed to warm to ambient 
temperature and was stirred for 1 h.  The resulting solution was cooled to 0°C whereupon 1.84 g 
of β-lactone (15.8 mmol, 1.0 equiv) was added.  The reaction remained in the ice bath, and 
allowed to warm slowly to ambient temperature overnight.  In the morning the reaction mixture 
was cooled to 0 °C and quenched with 0.5M HCl (50 mL).   The layers were separated and the 
aqueous layer was extracted with CH2Cl2 (3 x 50 mL).  The combined organic extracts were 
dried (MgSO4), and concentrated.  The crude product was purified by flash chromatography on 
silica gel (5% MeOH/CH2Cl2) to afford 1.93 g (100%) of the title β-hydroxy amide as a clear 
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colorless oil.  [α]21
D
  +34.3 (c 1.68, CHCl3). IR (thin film): 3440, 2934, 1653, 1445, 1192, 1126, 
997 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 4.24-4.18 (m, 1H), 3.69 (s, 3H), 3.44 (d, J = 5.4 Hz, 2 
H), 3.40 (s, 3H), 3.20 (s, 3H), 2.71-2.58 (m, 2 H), 1.63 (s, 1H); 
13
C NMR (125 MHz, CDCl3) δ 
173.2, 75.7, 66.9, 61.2, 59.1, 34.9, 31.8; HRMS (ES) m/z calcd for C7H15NO4Na (M + Na)
+
: 
200.0899; found: 200.0908. 
 
 (R)-3-(tert-Butyldimethylsilyloxy)-N,4-dimethoxy-N-
methylbutanamide (62): To a −60 °C solution of 2.0 g of the β-hydroxy 
amide (11.3 mmol, 1.0 equiv) in 32.0 mL of CH2Cl2 was added 5.26 mL 
of 2,6 lutidine (45.2 mmol, 4.0 equiv) followed by 3.89 mL of TBDMSOTf (16.9 mmol, 1.5 
equiv) dropwise.  The resulting solution was maintained at −60 °C overnight.  Saturated aqueous 
NaHCO3 (100 mL) was added and the mixture was extracted with CH2Cl2 (3 x 100 mL).  The 
combined organics were washed with 1M NaHSO4 (200 mL), dried over MgSO4 and 
concentrated.  The crude product was purified by flash chromatography on silica gel (30% 
EtOAc/hexanes) to afford 3.28 g (99%) of the title amide as a clear colorless oil.  [α]21
D
  +18.2 (c 
1.05, CHCl3). IR (thin film): 2930, 1666, 1464, 1386, 1252, 1107, 991, 835, 778 cm
-1
; 
1
H NMR 
(500 MHz, CDCl3) δ 4.37-4.33 (m, 1H), 3.68 (s, 3H), 3.39 (dd, J = 10.0, 4.0 Hz, 1H), 3.34 (s, 
3H), 3.33 (dd, J = 10.0, 5.0 Hz, 1H), 3.17 (s, 3H), 2.70 (br dd, J = 15.0, 7.5 Hz, 1H), 2.53 (dd, J = 
15.0, 5.0 Hz, 1H), 0.86 (s, 9H), 0.08 (s, 3H), 0.05 (s, 3H); 
13
C NMR (125 MHz, CDCl3) δ 172.2, 
76.8, 68.4, 61.3, 59.1, 36.9, 31.9, 25.8 (3C), 18.1, −4.7, −4.9; HRMS (ES) m/z calcd for 
C13H29NO4NaSi (M + Na)
+ 
: 314.1764; found: 314.1743. 
 
 (R)-3-(tert-Butyldimethylsilyloxy)-4-methoxybutanal (63):  To a 
−78 °C solution of 2.62 g of the amide (9.00 mmol, 1.0 equiv) in 54.0 mL of 
THF was added 10.8 mL of 
i
Bu2AlH (10.8 mmol of a 1.0 M solution in hexane, 1.2 equiv) 
dropwise via syringe pump over 2 h. The resulting colorless solution was maintained at −78 °C 
for 2 h whereupon saturated aqueous Rochelle salt (100 mL) was added and the resulting 
emulsion was warmed to ambient temperature, and stirred for 2 h.  The resulting mixture was 
extracted with Et2O (3 x 100 mL), dried over MgSO4 and concentrated.  Purification of the crude 
oil by flash chromatography on silica gel (10% EtOAc/hexanes) afforded 2.00 g (95%) of the 
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title aldehyde as a clear colorless oil.  [α]22
D
  +7.30 (c 1.36, CHCl3). IR (thin film): 17.28, 1469, 
1254, 1111, 1009, 837, 778 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 9.796 (t, J = 2.1 Hz, 1H), 4.34-
4.28 (m, 1H), 3.41 (dd, J = 9.6, 5.1 Hz, 1H), 3.35 (s, 3H), 3.30 (dd, J = 9.6, 6.0 Hz, 1H), 2.63 
(ddd, J = 15.9, 5.1, 1.8 Hz, 1H), 2.55 (ddd, J = 15.9, 6.6, 2.7 Hz, 1H), 0.86 (s, 9H), 0.08 (s, 3H), 
0.07 (s, 3H); 
13
C NMR (75 MHz, CDCl3) δ 201.4, 76.5, 67.2, 59.1, 48.8, 25.7 (3C), 18.0, −4.5, 
−5.0; HRMS (ES) m/z calcd for C11H24O3NaSi (M + Na)
+
 : 255.1392; found: 255.1374. 
 
 
         (3R, 4S)-3-Methyl-4-[(2R)-2-tert-butyldimethylsilyloxy-3-
methoxypropanyl]oxetan-2-one (64): To a solution of 0.457 g of 
LiClO4 (4.30 mmol, 1.0 equiv) and 0.170 g of TMS-quinidine (0.430 mmol, 0.1 equiv) in Et2O 
(7.50 mL) at ambient temperature was added CH2Cl2 (22.0 mL) via syringe.  The solution was 
cooled to −78 °C.  To this homogeneous solution was added 1.87 mL of Hunig’s base (10.8 
mmol, 2.5 equiv) followed by 1.0 g of the aldehyde (4.30 mmol, 1.0 equiv).  To this solution was 
added 0.751 mL of propionyl chloride (8.60 mmol, 2.0 equiv) as a solution in 7.5 mL of CH2Cl2 
over a period of 4 h via syringe pump.  The reaction was maintained at −78°C overnight, then 
quenched with Et2O (30 mL) and filtered through a plug of silica gel.  The filtrate was 
concentrated under reduced pressure.  Purification of the crude oil by flash chromatography on 
silica gel (10% EtOAc/hexanes) afforded 0.965 g (78%) of the title compound as a clear 
colorless oil.  [α]23
D
 +63.3 (c 0.610, CHCl3). IR (thin film): 1819, 1468, 1249, 1079, 837 cm
-1
; 
1
H 
NMR (300 MHz, CDCl3) δ 4.79 (ddd, J = 10.5, 6.6, 3.0 Hz, 1H), 4.01-3.94 (m, 1H), 3.77 (dq, J = 
7.8, 6.6 Hz, 1H), 3.36 (dd, J = 9.6, 4.8 Hz, 1H), 3.34 (s, 3H), 3.30 (dd, J = 9.9, 5.7 Hz, 1H), 1.90 
(ddd, J = 14.7, 10.5, 2.7 Hz, 1H), 1.27 (ddd, 14.4, 9.9, 2.7 Hz, 1H), 1.27 (d, 7.8 Hz, 3H), 0.88 (s, 
9H), 0.08 (s, 6H); 
13
C NMR (75 MHz, CDCl3) δ 172.6, 77.1, 72.3, 67.4, 59.1, 47.1, 34.9, 25.1 
(3C), 18.1, 8.4, −4.5, −5.0; HRMS (EI) m/z calcd for C14H29O4Si (M)
+
 : 289.1835; found: 
289.1827. 
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 (2S,3R,5R)-5-(tert-Butyldimethylsilyloxy)-3-hydroxy-
N,6-dimethoxy-N,2-dimethylhexanamide: To a 0 °C solution of 
1.01 g of N,O-dimethylhydroxylamine hydrochloride (10.4 mmol, 
2.0 equiv) in 40.0 mL of CH2Cl2 was added 10.4 mL of dimethylaluminum chloride (10.4 mmol 
of 1M hexanes solution, 2.0 equiv).  The resulting solution was allowed to warm to ambient 
temperature and stirred for 1 h.  The resulting solution was cooled to −45 °C whereupon 1.5 g of 
the β-lactone (5.2 mmol, 1.0 equiv) was added as a solution in 8.00 mL of CH2Cl2.  The reaction 
was maintained at −45 °C for 3 h.  Saturated aqueous Rochelle salt (60 mL) was added, and the 
reaction was allowed to warm to ambient temperature and stir for 2 h.  The layers were separated 
and the aqueous layer was extracted with CH2Cl2 (3 x 50 mL).  The combined organics were 
dried over MgSO4, filtered, and concentrated.  The crude product was purified by flash 
chromatography on silica gel (40% EtOAc/hexanes) to afford 1.67 g (92.0%) of the β-hydroxy 
amide as a clear colorless oil. [α]23
D
  +13.7 (c 1.63, CHCl3). IR (thin film): 3469, 2932, 1641, 
1462, 1250, 992, 836 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 4.08-4.10 (m, 2H), 3.86 (br s, 1H), 
3.86 (s, 3H), 3.35 (dd, J = 5.1, 0.9 Hz, 2H), 3.33 (s, 3H), 3.17 (s, 3H), 2.83 (br. s, 1H), 1.69 (ddd, 
14.1, 10.2, 3.3 Hz, 1H), 1.47 (ddd, 14.1, 7.8, 2.1 Hz, 1H), 1.17 (d, J = 6.9 Hz, 3H), 0.87 (s, 9H), 
0.08 (s, 3H), 0.07 (s, 3H); 
13
C NMR (75 MHz, CDCl3) δ 177.7, 77.2, 69.1, 68.3, 61.5, 59.0, 40.1, 
38.7, 31.9, 25.8 (3C), 18.1, 11.2, −4.5, −4.9; HRMS (ES) m/z calcd for C16H35NO5NaSi (M + 
Na)
+
 : 372.2182; found: 372.2149. 
 
 
 (2S,3R,5R)-5-(tert-Butyldimethylsilyloxy)-N,6-dimethoxy-N,2-
dimethyl-3-(triethylsilyloxy)hexanamide: To a −60 °C solution of 
2.16 g of the β-hydroxy amide (6.18 mmol, 1.0 equiv) in 17.6 mL 
of CH2Cl2 was added 2.88 mL of 2,6 lutidine (24.7 mmol, 4.0 equiv) followed by 2.13 mL of 
TESOTf (9.27 mmol, 1.5 equiv) dropwise.  The resulting solution was maintained at −60 °C for 
2 h.  Saturated aqueous NaHCO3 (30 mL) was added and the mixture was diluted with CH2Cl2 
(50 mL) and more aqueous NaHCO3 (50 mL) before being extracted with CH2Cl2 (3 x 75 mL).  
The combined organics were washed with 1M NaHSO4 (3 x 150 mL), dried over MgSO4 and 
concentrated.  The crude product was purified by flash chromatography on silica gel (30% 
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Et2O/pentane) to afford 2.58 g (90%) of the title amide as a clear colorless oil. [α]
22
D
 
 −1.46 (c 
1.88, CHCl3). IR (thin film): 2954, 1669, 1461, 1249, 1110, 834, 740 cm
-1
; 
1
H NMR (300 MHz, 
CDCl3) δ 4.07 (q, J = 5.7 Hz, 1H), 3.83 (ddd, J = 12.6, 6.3, 3.9 Hz, 1H), 3.67 (s, 3H), 3.33 (dd, J 
= 9.6, 3.6 Hz, 1H), 3.32 (s, 3H), 3.27 (dd, J = 9.9, 6.0 Hz, 1H), 3.17 (s, 3H), 2.92 (m, 1H), 1.67 
(t, 6.3 Hz, 2H), 1.13 (d, J = 6.9 Hz, 3H), 0.96 (t, 8.1 Hz, 9H), 0.88 (s, 9H), 0.61 (q, J = 8.1 Hz, 
6H), 0.08 (s, 3H), 0.07 (s, 3H); 
13
C NMR (75 MHz, CDCl3) δ 175.6, 77.6, 70.9, 69.4, 61.1, 58.8, 
41.6, 41.5, 32.2, 25.9 (3C), 18.2, 12.8, 6.9 (3C), 5.2 (3C), −3.9, −4.6; HRMS (ES) m/z calcd for 
C22H49NO5NaSi2 (M + Na)
+
: 486.3047; found: 486.3007. 
 
(2S,3R,5R)-5-(tert-Butyldimethylsilyloxy)-6-methoxy-2-methyl-3-
(triethylsilyloxy)hexanal (66): To a −78 °C solution of 2.30 g of the 
amide (4.96 mmol, 1.0 equiv) in 30 mL of THF was added 5.96 mL of 
i
Bu2AlH (5.96 mmol, 1.0 M hexanes solution, 1.2 equiv) dropwise via syringe pump over 1 h. 
The resulting colorless solution was maintained at −78 °C for 3 h whereupon saturated aqueous 
Rochelle salt (30 mL) was added and the resulting emulsion was warmed to ambient 
temperature, and stirred for 2 h.  The resulting mixture was diluted with Et2O (50 mL) and H2O 
(50 mL) before being extracted with Et2O (3 x 100 mL). The combined organic layers were dried 
over MgSO4 and concentrated.  Purification of the crude oil by flash chromatography on silica 
gel (5% EtOAc/hexanes) afforded 1.90 g (95%) of the title aldehyde as a clear colorless oil. [α]22
D
 
 
+54.0 (c 1.01, CHCl3). IR (thin film): 2955, 1729, 1461, 1251, 1109, 834, 776 cm
-1
; 
1
H NMR 
(300 MHz, CDCl3) δ 9.79 (s, 1H), 4.29 (dt, J = 6.0, 3.3 Hz, 1H), 3.90-3.82 (m, 1H), 3.32 (s, 3H), 
3.28 (d, J = 5.1 Hz, 2H), 2.50 (ddd, J = 13.8, 6.9, 3.0 Hz, 1H), 1.70-1.63 (m, 2H), 1.05 (d, J = 7.2 
Hz, 3H), 0.94 (t, 7.8 Hz, 9H), 0.88 (s, 9H), 0.61 (q, J = 7.8 Hz, 6H), 0.08 (s, 3H), 0.07 (s, 3H); 
13
C NMR (75 MHz, CDCl3) δ 205.1, 77.6, 69.8, 69.2, 58.8, 52.2, 40.1, 25.8 (3C), 18.2, 7.8, 6.8 
(3C), 5.2 (3C), −3.9, −4.7; HRMS (ES) m/z calcd for C20H44O4NaSi2 (M + Na)
+
: 427.2676; 
found: 427.2673. 
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 (3S,4R)-4-((R)-2-(tert-Butyldimethylsilyloxy)-3-
methoxypropyl)-3-methyloxetan-2-one (67): To a solution of 
0.501 g of LiI (3.75 mmol, 3.0 equiv) and 0.050 g of TMS-quinine 
(0.125 mmol, 0.1 equiv) in Et2O (0.25 mL) at ambient temperature was added CH2Cl2 (2.50 mL) 
via syringe.  The solution was cooled to −78 °C.  To this homogeneous solution was added 0.544 
mL of Hunig’s base (3.12 mmol, 2.5 equiv) followed by 0.50 g of the aldehyde (1.25 mmol, 1.0 
equiv).  To this solution was added 0.218 mL of propionyl chloride (2.5 mmol, 2.0 equiv) as a 
solution in 2.18 mL of CH2Cl2 over a period of 5 h via syringe pump.  The reaction was 
maintained at −78 °C overnight, then quenched with Et2O (30 mL) and filtered through a plug of 
silica gel with excess ether.  The filtrate was concentrated under reduced pressure.  Purification 
of the crude oil by flash chromatography on silica gel (5% EtOAc/hexanes) afforded 0.445 g 
(77%) of the title compound as a clear colorless oil. [α]21
D
  −20.4 (c 1.27, CHCl3). IR (thin film): 
1829, 1462, 1252, 1118, 836 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 4.43 (dd, J = 11.1, 6.3 Hz, 
1H), 4.05 (dt, J = 6.9, 1.5 Hz, 1H), 3.82-3.69 (m, 2H), 3.33 (s, 3H), 3.28 (dd, J = 5.1, 0.6 Hz, 
2H), 1.86-1.72 (m, 1H), 1.75 (t, J = 6.3 Hz, 2H), 1.32 (d, 7.8 Hz, 3H), 0.95 (t, 7.8 Hz, 9H), 0.88 
(s, 9H), 0.85 (d, J = 6.6 Hz, 3H), 0.60 (q, J = 8.1 Hz, 6H), 0.08 (s, 3H), 0.07 (s, 3H); 
13
C NMR 
(75 MHz, CDCl3) δ 172.7, 77.2, 76.3, 69.4, 67.8, 58.9, 46.4, 40.7, 37.8, 25.8 (3C), 18.1, 8.5, 7.4, 
6.9 (3C), 5.1 (3C), −4.2, −5.6; HRMS (ES) m/z calcd for C23H48O5NaSi2 (M + Na)
+
: 483.2938; 
found: 483.2942. 
 
 (2R,3S,4R,5R,7R)-7-(tert-Butyldimethylsilyloxy)-3-
hydroxy-N,8-dimethoxy-N,2,4-trimethyl-5-
(triethylsilyloxy)octanamide: To a solution of 0.33 g of N,O-
dimethylhydroxylamine hydrochloride (3.4 mmol, 2.0 equiv) in 15 mL of CH2Cl2 at ambient 
temperature was added 3.4 mL of dimethylaluminum chloride (3.4 mmol of 1M hexanes 
solution, 2.0 equiv).  The resulting solution was allowed to stir at ambient temperature for 1 h.  
The resulting solution was cooled to −45 °C whereupon 0.80 g of β-lactone (1.77 mmol, 1.0 
equiv) was added.  The reaction was maintained at −45 °C overnight.  Saturated aqueous 
Rochelle salt (30 mL) was added, and the reaction was allowed to warm to ambient temperature 
and stir for 4 h.  The mixture was diluted with CH2Cl2 (40 mL) and H2O (40 mL) and the layers 
were separated and the aqueous layer was extracted with CH2Cl2 (3 x 100 mL).  The combined 
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organics were dried over MgSO4, filtered, and concentrated.  The crude material contained 0.818 
g of a mixture of TES protection at the C5 oxygen.  The mixture was separated via flash 
chromatography to yield 0.418 g of the title compound (45% yield), and 0.400 g of the diol (55% 
yield).  [α]22
D
  −1.2 (c 0.98, CHCl3). IR (thin film): 3461, 2954, 1642, 1461, 1249, 1002, 835, 776, 
739 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 4.19 (dt, J = 6.9, 1.8 Hz, 1H), 4.06 (d, J = 2.1 Hz, 1H), 
3.81-3.74 (m, 2H), 3.69 (s, 3H), 3.33 (dd, J = 9.9, 3.6 Hz, 1H), 3.32 (s, 3H), 3.26 (dd, J = 9.9, 5.7 
Hz, 1H), 3.19 (s, 3H), 3.00-2.96 (m, 1H), 1.77-1.57 (m, 3H), 1.13 (d, J = 7.2 Hz, 3H), 0.94 (t, 8.1 
Hz, 9H), 0.88 (s, 9H), 0.81 (d, J = 6.9 Hz, 3H), 0.61 (q, J = 7.8 Hz, 6H), 0.08 (s, 3H), 0.07 (s, 
3H); 
13
C NMR (125 MHz, CDCl3) δ 177.8, 77.1, 72.7, 70.5, 69.4, 61.3, 58.8, 39.6, 39.5, 36.7, 
25.9 (3C), 18.2, 10.3, 9.8, 6.8 (3C), 5.1 (3C), −4.1, −4.7; HRMS (ES) m/z calcd for 
C25H55NO6NaSi2 (M + Na)
+
: 544.3466; found: 544.3467. 
 
 (2R,3S,4S,5R,7R)-7-(tert-Butyldimethylsilyloxy)-3,5-
dihydroxy-N,8-dimethoxy-N,2,4-trimethyloctanamide: 
Procedure Above.  [α]21
D
  +19.4 (c 0.72, CHCl3). IR (thin film): 
3440, 1638, 1461, 1252, 1107, 989, 835 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 4.38 (s br, 1H), 
4.10-4.07 (m, 1H), 4.04-4.01 (m, 1H), 3.83 (dt, J = 9.0, 2.4 Hz, 1H), 3.71 (d, J = 6.0 Hz, 1H), 
3.68 (s, 3H), 3.36 (dd, J = 5.4, 2.4 Hz, 2H), 3.32 (s, 3H), 3.16 (s, 3H), 3.02 (s br, 1H), 1.80-1.76 
(m, 1H), 1.76-1.71 (m, 1H), 1.47 (ddd, J = 13.8, 7.2, 1.2 Hz, 1H), 0.86 (s, 9H), 0.82 (d, J = 7.2 
Hz, 3H), 0.08 (s, 3H), 0.06 (s, 3H); 
13
C NMR (150 MHz, CDCl3) δ 178.3, 77.1, 74.3, 69.9, 69.3, 
61.5, 58.9, 39.3, 37.5, 36.0, 31.8, 25.8 (3C), 18.0, 11.9, 10.1, −4.5, −5.0; 
 
  (2R,3S,4S,5R,7R)-7-(tert-Butyldimethylsilyloxy)-N,8 
dimethoxy-N,2,4-trimethyl-3,5-bis(triethylsilyloxy) 
octanamide (68):  
 
From Mono-alcohol:  
To a −60 °C solution of 0.96 g of the mono-alcohol (1.84  mmol, 1.0 equiv) in 5.29 mL of 
CH2Cl2 was added 0.857 mL of 2,6-lutidine (7.36 mmol, 4.0 equiv) followed by 0.624 mL of 
TESOTf (2.76 mmol, 1.5 equiv) slowly via syringe.  The resulting solution was maintained at 
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−60 °C for 3 hours, whereupon the crude reaction mixture was combined with that of the diol, 
and quenched concurrently.  
 
From Diol:  
To a −60 °C solution of 0.722 g of the diol (1.77 mmol, 1.0 equiv) in 6.32 mL of CH2Cl2 was 
added 1.23 mL of 2,6-lutidine (10.62 mmol, 6.0 equiv) followed by 1.00 mL of TESOTf (4.42 
mmol, 2.5 equiv) slowly via syringe.  The resulting solution was maintained at −60 °C for 3 
hours.  Whereupon the crude mixture was combined with that of the mono-alcohol and quenched 
with 15 mL of saturated aqueous NaHCO3.  The resulting mixture was extracted with CH2Cl2 (3 
x 30 mL).  The organic layers were combined and concentrated in vacuo, before being diluted in 
EtOAc (30 mL) and washed with 1M NaHSO4 (30 mL), dried over MgSO4, and concentrated.  
The crude colorless oil was purified by column chromatography using 10% to 15% EtOAc in 
hexane, yielding 2.20 g (95%) of a clear colorless oil.  Due to a rapid rearrangement, this 
compound was carried on without complete characterization. 
 
 (3R,4S,5S,6R,8R)-8-(tert-Butyldimethylsilyloxy)-9-
methoxy-3,5-dimethyl-4,6-bis(triethylsilyloxy)nonan-2-one 
(69): To a 0 °C solution of 1.68 g of the amide (2.64 mmol, 
1.0 equiv) in 16.8 mL of THF was added 3.73 mL of methyl 
magnesiumbromide (3.17 mmol of a 0.85 M solution, 1.2 equiv) over 1 hour via syring pump.  
The resulting solution remained in the cold bath and was allowed to warm to ambient 
temperature over 6 h.  Saturated aqueous NH4Cl (30 mL) was added and the resulting mixture 
was extracted with Et2O (3 x 60 mL).  The organic layers were combined and dried over MgSO4, 
filtered and concentrated.  The crude oil was purified by flash chromatography on silica gel (10% 
EtOAc/hexanes) to yield 1.44 g (92%) of a clear colorless oil. [α]22
D
  −37.8 (c 1.25, CHCl3). IR 
(thin film): 2878, 1714, 1461, 1415, 1383,1359, 1249 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 4.24 
(dd, J = 7.2, 1.8 Hz, 1H), 3.97-3.92 (m, 1H), 3.73-3.65 (m, 1H), 3.33 (s, 3H), 3.29-3.26 (m, 2H), 
2.67 (dq, J = 6.9, 1.8 Hz, 1H), 2.15 (s, 3H), 1.83-1.74 (m, 2H), 1.73-1.66 (m, 1H), 1.07 (d, 7.2 
Hz, 3H), 0.98-0.90 (m, 18H), 0.87 (s, 9H), 0.84 (d, J = 7.2 Hz, 3H), 0.64-0.53 (m, 12H), 0.06 (s, 
6H); 
13
C NMR (75 MHz, CDCl3) δ 210.9, 76.9, 73.1, 70.2, 69.4, 58.9, 50.3, 42.9, 40.6, 28.6, 
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25.8 (3C), 18.2, 9.7, 9.5, 7.1 (3C), 7.0 (3C), 6.0 (3C), 5.6 (3C), 5.4 (3C), −4.3, −4.7; HRMS (ES) 
m/z calcd for C30H66O5NaSi3 (M + Na)
+
: 613.4116; found: 613.4160. 
 
 (3R,4S,5S,6R,8R)-8-(tert-butyldimethylsilyloxy)-9-methoxy-
3,5-dimethyl-4,6-bis(triethylsilyloxy)-2-trimethylsilyloxy-non-
1-ene: To a −78 °C solution of 1.30 g of ketone (2.19 mmol, 1.0 
equiv) in 8.64 mL of THF was added 2.42 mL of a 1M solution  of NaHMDS (2.42 mmol, 1.1 
equiv).  The solution was stirred for 30 minutes at −78 °C before warming to 0 °C, and allowing 
to stir for an additional 30 minutes.  After which, 1.27 mL of 2,6-lutidine (10.9 mmol, 5.0 equiv) 
was added, followed by 0.85 mL of TMSCl (8.76 mmol, 4.0 equiv).  The resulting solution was 
allowed to stir at 0 °C for 30 minutes before warming to ambient temperature and stirring for 2 
hours.  Saturated aqueous NaHCO3 (20 mL) was added and the resulting mixture was extracted 
with Et2O (3 x 20 mL).  The organic layers were combined and dried over Na2SO4, filtered and 
concentrated.  The clear colorless oil was passed through a plug of IATRO
®
 beads with Et2O, 
and used in the following reaction without further purification.  
 
2-(Chloromethyl)-tetrahydro-2H-pyran (50): To a 0 °C solution of 30.0 g of the 
starting alcohol (.258 mol) in CH2Cl2 (240 mL), was added 23.0 mL of pyridine 
(0.284 mol), then 19.7 mL of thionyl chloride (0.271 mol) was added slowly.  The resulting 
solution was maintained at 0 °C for 30 minutes, before heating to reflux overnight.  The resulting 
dark yellow solution was quenched at 0 °C with H20 (250 mL) whereupon it was warmed to 
ambient temperature.  The resulting mixture was decanted into a seperatory funnel that contained 
H2O (100 mL) and CH2Cl2 (100 mL).  The resulting mixture was extracted with CH2Cl2 (3 x 250 
mL), dried over MgSO4, filtered, and concentrated.  27.0 g (78%) of a clear colorless oil was 
isolated from vacuum distillation at 73 °C and 15 mmHg.   IR (thin film): 2940, 2850, 1440, 
1095, 1046, 742 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 4.07-4.01 (m, 1H), 3.53-3.43 (m, 4H), 
1.91-1.85 (m, 1H), 1.72-1.68 (m, 1H), 1.65-1.33 (m, 4H); 
13
C NMR (75 MHz, CDCl3) δ 77.3, 
68.7, 47.6, 29.2, 25.6, 23.0; HRMS m/z calcd for C6H11OCl: 134.0498; found: 134.0499. 
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Hex-5-yn-1-ol (51): To a −78 °C solution of 0.100 g (0.250 mmol) of 
Fe(NO3)3 in 400 mL of NH3 in a 3-neck flask with dry-ice/acetone coldfinger 
was added 8.05 g of sodium metal (0.350 mol) in approximately ¼ inch cubes.  The resulting 
grey mixture was maintained at −78 °C for 30 minutes whereupon 13.5 g of the chloride (0.100 
mol) was added dropwise.  The removal of the dry-ice/acetone bath warmed the mixture to −33 
°C and was maintained at this temperature for 3 h.  17.6 g of solid NH4Cl (0.330 mol) was 
added, and the coldfinger was removed to allow the evaporation of the ammonia.  Et2O (6 x 100 
mL) was used to extract from the powdered remainder of the reaction mixture.  9.00 g of a 
yellow oil was extracted, and used crude in the following reaction. IR (thin film): 3297, 2942, 
2115, 1454, 1062 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 3.67 (t, J = 6.0 Hz, 2H), 2.23 (dt, J = 6.9, 
2.7 Hz, 2H), 1.95 (t, J = 2.7 Hz, 1H), 1.74-1.59 (m, 4H), 1.42 (br s, 1H); 
13
C NMR (75 MHz, 
CDCl3) δ 84.5, 68.7, 62.5, 31.9, 24.9, 18.4. 
 
 (Hex-5-ynyloxy)trimethylsilane:  To a 0 °C solution of 11.2 g of 
imidazole (165 mmol) in 300 mL of CH2Cl2 was added 9.00 g of the alcohol 
(91.7 mmol), followed by 17.3 g of TMSCl (138 mmol) dropwise.  The resulting white, opaque 
mixture is maintained at ambient temperature for 48 h, whereupon H2O (300 mL) is added.  This 
mixture is extracted with CH2Cl2 (3 x 300 mL).  The combined organic layers were concentrated 
and filtered through a plug of silica gel.  The filtrate was used crude in the next reaction. 
 
Hept-5-yn-1-ol (52):  To a −78 °C solution of 71.3 mL of nBuLi (114 
mmol of a 1.60 M solution) in 225 mL of THF was added 13.0 g of the 
alkyne (76.0 mmol) slowly.  The resulting solution was maintained at −78 °C for 1 h, whereupon 
14.2 mL of methyliodide (228 mmol) was added via syringe.  The reaction was maintained at 
−78 °C for 1 h before being warmed to ambient temperature for 2 h.  A 1M solution of HCl was 
added (200 mL) at ambient temperature, and after 30 minutes the resulting mixture was extracted 
with Et2O  (3 x 200 mL)  Purification of  the crude yellow oil by flash chromatography on silica 
gel (20% EtOAc/hexanes) afforded 7.15 g (63.1 % 3 steps) of the alcohol as a clear colorless 
liquid.  IR (thin film): 3347, 2939, 1436, 1060 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 3.67 (t, J = 
 64 
6.0 Hz, 2H), 2.21 (m, 2H), 1.77 (t, J = 2.4 Hz, 3H), 1.72-1.55 (m, 4H), 1.37 (br s, 1H); 
13
C NMR 
(75 MHz, CDCl3) δ 78.9, 75.8, 62.5, 31.9, 25.3, 18.5, 3.4. 
 
Hept-5-ynal (53):  To a solution of 3.35 g of alcohol (29.8 mmol) in 100 
mL of CH2Cl2 at ambient temperature is added 8.0 g of celite.  The 
resulting mixture is cooled to 0°C whereupon 9.65 g of PCC (44.8 mmol) is added in small 
portions.  The resulting orange/brown mixture is maintained at 0 °C for 1 h before warming to 
ambient temperature for 2 h.  The heterogeneous mixture is filtered through a pad of florisil, and 
rinsed thoroughly with excess CH2Cl2.  The clear colorless solution is used crude in the 
following reaction. 
 
 (R)-4-(Hex-4-ynyl)oxetan-2-one (54): To an ambient temperature 
solution of 0.246 g of amine catalyst (59) (0.363 mmol, 0.1 equiv) in 
20 mL of CH2Cl2 was slowly added 0.363 mL of Me2AlCl (0.363 mmol, 1.0 M solution in 
hexane, 0.1 equiv).  This homogeneous mixture was stirred at ambient temperature for 1 hr 
before being cooled to −78 °C.  To this was added 1.07 mL of iPr2NEt (6.17 mmol, 1.7 equiv) 
followed by 0.510 mL of acetyl bromide (6.89 mmol, 1.9 equiv) over a period of 60 seconds.  
The resulting yellow solution was stirred exactly 120 seconds at −78 °C whereupon 0.400 g of 
crude aldehyde 3.63 mmol, 1.0 equiv) was added dropwise via syringe as a solution in 5 mL of 
CH2Cl2.  The reaction was maintained at −78 °C overnight.  Saturated aqueous NH4Cl (50 mL) 
was added and the mixture was extracted with CH2Cl2 (3 x 50 mL).  The combined organics 
were dried over MgSO4, filtered, and concentrated.  The crude product was purified by flash 
chromatography on silica gel (20% EtOAc/hexanes) to afford 0.380 g (51% 2 steps) of the β-
lactone as a clear colorless oil.  [α]22
D
 +23.07 (c 1.66, CHCl3). IR (thin film): 2921, 2863, 1826, 
1413, 1133, 870 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 4.54-4.50 (m, 1H), 3.51 (ddd, J = 9.9, 3.6, 
0.6 Hz, 1H), 3.08 (ddd, J = 9.9, 2.7, 0.9 Hz, 1H), 2.21-2.18 (m, 2H), 1.95-1.88 (m, 2H), 1.76 (t, J 
= 2.7 Hz, 3H), 1.66-1.50 (m, 2H); 
13
C NMR (75 MHz, CDCl3) δ 168.1, 77.8, 76.5, 70.8, 42.9, 
33.6, 24.3, 18.2, 3.3; HRMS (EI) m/z calcd for C9H12O2 (M)
+
: 152.0837; found: 152.0835. 
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 (R)-3-Hydroxy-N-methoxy-N-methylnon-7-ynamide: To a 
solution of 1.46 g of N,O-dimethylhydroxylamine 
hydrochloride (15.0 mmol, 2.0 equiv) in 50 mL of CH2Cl2 at 
ambient temperature was added 15.0 mL of dimethylaluminum chloride (15.0 mmol of 1M 
hexanes solution, 2.0 equiv).  The resulting solution was allowed to stir at ambient temperature 
for 1.5 h, then was cooled to 0 °C whereupon 1.15 g of β-lactone (7.50 mmol) was added as a 
solution in 10 mL of CH2Cl2.  The reaction remained in the cold bath, and was allowed to warm 
to ambient temperature over 3 h.  To this was added 0.5 N HCl (100 mL), and the mixture was 
extracted with CH2Cl2 (3 x 100 mL).  The combined organics were dried over MgSO4, filtered, 
and concentrated.  The crude product was purified by flash chromatography on silica gel (75% 
EtOAc/hexanes) to afford 1.31 g (81.8%) of the β-hydroxy amide as a clear yellow oil.  [α]22
D
  
−33 (c 0.73, CHCl3). IR (thin film): 3447, 2920, 1645, 1437, 999 cm
-1
; 
1
H NMR (300 MHz, 
CDCl3) δ 4.04-3.98 (m, 1H), 3.81 (d, J =  3.0 Hz, 1H), 3.65 (s, 3H), 3.16 (s, 3H), 2.64 (d, J= 16.5 
Hz, 1H), 2.42 (dd, J = 16.8, 9.6 Hz, 1H), 2.18-2.10 (m, 2H), 1.73 (t, J = 2.7 Hz, 3H), 1.66-1.50 
(m, 4H); 
13
C NMR (75 MHz, CDCl3) δ 173.7, 78.8, 75.6, 67.4, 61.1, 38.1, 35.5, 31.7, 24.9, 18.5, 
3.4; HRMS (ES) m/z calcd for C11H19NO3Na (M + Na)
+
: 236.1263; found: 236.1253. 
 
 (R)-N-Methoxy-3-(4-methoxybenzyloxy)-N-methylnon-7-
ynamide (56):  To an ambient temperature solution of 0.75 g of 
alcohol (3.53 mmol, 1.0 equiv) in 10.7 mL of CH2Cl2 was 
added 2.0 g of freshly prepared p-methoxybenzyl acetimidate (7.08 mmol, 2 equiv) in a small 
amount of CH2Cl2.  To this homogeneous solution was added 0.246 g of camphor sulfonic acid 
(1.06 mmol, 0.3 equiv).  The heterogeneous mixture was allowed to stir at ambient temperature 
for five hours before being quenched with saturated aqueous NaHCO3 (20 mL).  The aqueous 
layer was extracted with CH2Cl2 (3 x 20 mL), and the combined organic extracts were dried 
(MgSO4) and concentrated to a yellowish semi-solid.  This semi-solid was triturated with a small 
amount of CH2Cl2 (~2 mL), and cooled on ice.  Using pipette filtration the CH2Cl2 was removed, 
leaving behind a white semi-solid.  This filtration was repeated twice more, to yield a white 
crystalline solid, which was discarded.  The combined organic filtrates were purified by MPLC 
(gradient elution 10-40% ethyl acetate in hexanes on silica gel) to afford 1.0 g (74%) of the title 
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compound as a clear colorless oil.  [α]22
D
  +11.1 (c 1.21, CHCl3). IR (thin film): 2937, 1659, 1512, 
1247 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ7.25 (d, J = 8.7 Hz, 2H), 6.85 (d, J = 8.7 Hz, 2H), 4.48 
(d, J = 2.1 Hz, 2H), 3.99 (app dq, J = 5.4 Hz, 1H), 3.79 (s, 3H), 3.66 (s, 3H), 3.19 (s, 3H), 2.86 
(dd, J = 15.3, 7.2 Hz, 1H), 2.46 (dd, J = 15.3, 5.4 Hz, 1H), 2.16-2.10 (m, 2H), 1.78 (t, J = 2.7 Hz, 
3H), 1.68-1.50 (m, 4H); 
13
C NMR (75 MHz, CDCl3) δ 172.5, 159.0, 130.8, 129.3, 113.6, 78.9, 
75.6, 75.5, 71.5, 61.2, 55.2, 37.3, 34.0, 32.0, 24.8, 18.7, 3.4; HRMS (ES) m/z calcd for 
C19H27NO4Na (M + Na)
+
: 356.1838; found: 356.1820. 
 
 (R)-N,3-Dimethoxy-N-methylnon-7-ynamide (55): To a 0 °C 
solution of 1.78 g of the beta-alkoxy amide (8.30 mmol, 1.0 
equiv) in 54 mL of 3:8 DMF:THF was added 5.17 mL of 
methyl iodide (83.0 mmol).  To the resulting solution is added 0.832 g of sodium hydride (20.8 
mmol of 60% dispersion on mineral oil).  The resulting heterogeneous mixture is maintained at 0 
°C for 1 h, whereupon 20 mL of pH 7 phosphate buffer solution was added, and the mixture was 
diluted with brine (30 mL), before being extracted with CH2Cl2 (3 x 50 mL).  The organic 
fractions were combined and concentrated, taken up in EtOAc (50 mL), before washing with 
H2O (2 x 50 mL).  The organic solution was dried over MgSO4, filtered, and concentrated.  
Purification of the crude yellow oil by flash chromatography on silica gel (10% EtOAc in 
hexanes) afforded 1.51 g (80%) of a yellow oil.   [α]22
D
  −4.3 (c 0.55, CHCl3). IR (thin film): 
2937, 1662, 1447, 1100 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ3.77-3.69 (m, 1H), 3.68 (s, 3H), 
3.34 (s, 3H), 3.18 (s, 3H), 2.77 (dd, J = 15.3, 7.2 Hz, 1H), 2.39 (dd, J = 15.3, 6.0 Hz, 1H), 2.16-
2.11 (m, 2H), 1.76 (t, J = 2.4 Hz, 3H), 1.68-1.55 (m, 4H); 
13
C NMR (75 MHz, CDCl3) δ 172.5, 
78.8, 77.3, 75.7, 61.2, 57.2, 36.8, 33.5, 32.1, 24.7, 18.8, 3.4; HRMS m/z calcd for C12H21NO3Na: 
250.1419; found: 250.1402. 
 
 (R)-3-(4-Methoxybenzyloxy)non-7-ynal (58):  To a solution of 
0.190 g of amide (0.500 mmol, 1.0 equiv) in 7.25mL of THF at −78 
°C was added 0.60 mL of iBu2AlH (0.60 mmol, 1.0 M solution in hexane, 1.2 equiv) over one 
hour via syringe pump.  The resulting solution was stirred at −78 °C for 2 h before being 
quenched with approximately 20 mL of saturated aqueous Rochelle salt.  The heterogeneous 
mixture was stirred at ambient temperature before being separated.  The organic layer was 
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extracted with CH2Cl2 (3 x 20 mL), and the combined organics were dried over Na2SO4, filtered, 
and concentrated.  The crude product was purified by flash chromatography on silica gel (20% 
EtOAc/hexanes) to afford 0.160 g (97%) of a pale yellow oil.  [α]22
D
  −8.80 (c 1.14, CHCl3). IR 
(thin film): 2938, 1723, 1612, 1512, 1247 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 9.78 (t, J = 2.1 
Hz, 1H), 7.24 (d, J = 8.4 Hz, 2H), 6.87 (d, J = 8.4 Hz, 2H), 4.47 (d, J = 3.6 Hz, 2H), 3.96 (dtd, J 
= 5.4, 11.7 Hz, 1H), 3.80 (s, 3H), 2.67 (ddd, J = 9.0, 4.8, 2.4 Hz, 1H), 2.54 (ddd, J = 16.2, 4.8, 
1.8 Hz, 1H), 2.18-2.13 (m, 2H), 1.78 (t, J = 2.4 Hz, 3H), 1.72-1.62 (m, 2H), 1.60-1.48 (m, 2H);
 
13
C NMR (150 MHz, CDCl3) δ 201.6, 159.2, 130.2, 129.4, 113.8, 78.6, 76.0, 73.4, 70.8, 55.2, 
48.3, 33.3, 24.5, 18.6, 3.4; HRMS (EI) m/z calcd for C17H22NO3 (M)
+
: 274.156895; found: 
274.156129. 
 
 (R)-3-Methoxynon-7-ynal (57):   To a −78 °C solution of 0.20 g of 
amide 55 (0.88 mmol) in THF (8.8 mL) was added 1.06 mL of
 
i
Bu2AlH (1.06 mmol of a 1M solution) dropwise via syringe pump over 2 h.  The resulting 
solution was maintained at −78 °C for 1 h, whereupon saturated aqueous Rochelle salt (10 mL) 
was added, and the mixture was allowed to warm to ambient temperature for 2 h.  The mixture 
was extracted with Et2O (2 x 25 mL), dried (Na2SO4).  Solvent was reduced under vacuum to 
approximately 10 mL, whereupon the solution was filtered through a plug of silica gel, with 
excess Et2O rinses.  The filtrate was concentrated under vacuum and purified by flash 
chromatography on silica gel (20% EtOAc in hexanes) to afford 0.120 g of a semi-pure liquid.  
Due to the instability of the aldehyde product a complete characterization was not completed.    
1
H NMR (300 MHz, CDCl3) δ 9.81 (t, J = 2.1 Hz, 1H), 3.78-3.71 (m, 1H), 3.35 (s, 3H), 2.63 
(ddd, J = 16.2, 6.9, 2.4 Hz, 1H), 2.52 (ddd, J = 16.5, 5.1, 2.1 Hz, 1H), 2.19-2.13 (m, 2H), 1.77 (t, 
J = 2.4 Hz, 3H), 1.72-1.62 (m, 2H), 1.60-1.48 (m, 2H). 
 
 (2R,4R,5S,6S,7R,10S,12R)-2-(tert-
Butyldimethylsilyloxy)-10-hydroxy-1-
methoxy-12-(4-methoxybenzyloxy)-5,7-
dimethyl-4,6-bis(triethylsilyloxy)octadec-16-
yn-8-one (72):  To a −78 °C solution of 0.62 g 
of aldehyde (2.20 mmol, 1.1 equiv) in 20.5 mL of CH2Cl2 was added 1.36 g of silyl enol-ether 
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(2.05 mmol, 1.0 equiv).  To this solution was added 0.312 mL of BF3·Et2O (2.46 mmol, 1.2 
equiv) slowly via syringe.  The reaction was allowed to stir at −78 °C for 5 hours before being 
stored in a −78 °C freezer overnight.  In the morning 4.0 mL of NEt3 was added, and the solution 
was allowed to warm to ambient temperature before quenching with NH4Cl (20 mL).  The layers 
were separated and the aqueous was extracted with CH2Cl2 (2 x 40 mL).  The combined organic 
extracts were dried (Na2SO4) and concentrated.  The crude product was purified by flash 
chromatography on silica gel via mPLC with a gradient elution from 5% to 20% EtOAc in 
hexanes over 30 minutes to afford 1.25 g (66% over two steps) of a clear colorless oil of the title 
compound as a single diastereomer as assayed by 600 MHz 
1
H NMR.  [α]22
D
  −17.3 (c 0.96, 
CHCl3). IR (thin film): 3509, 2953, 1702, 1513, 1461, 1248, cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 
7.27 (d, J = 8.4 Hz, 2H), 6.86 (d, J = 8.4 Hz, 2H), 4.52 (d, J = 11.4 Hz, 1H), 4.45 (d, J = 11.4 Hz, 
1H), 4.29-4.26 (m, 1H), 4.23 (dd, J = 7.2, 1.8 Hz, 1H), 3.94 (ddd, J = 9.6, 5.4, 1.2 Hz, 1H), 3.79 
(s, 3H), 3.77-3.73 (m, 1H), 3.70-3.67 (m, 1H), 3.45 (d, J = 2.4 Hz, 1H), 3.33 (s, 3H), 3.31 (dd, J 
= 10.2, 3.0 Hz, 1H), 3.26 (dd, J = 10.2, 5.4 Hz, 1H), 2.66 (dq, J = 6.6, 1.8 Hz, 1H), 2.59-2.56 (m, 
2H), 2.15-2.12 (m, 2H), 1.78 (t, J = 2.4 Hz, 3H), 1.81-1.75 (m, 2H), 1.70-1.55 (m, 4H), 1.55-1.48 
(m, 2H), 1.08 (d, J = 7.2 Hz, 3H), 0.95 (t, J = 8.4 Hz, 9H), 0.93 (t, J = 7.8 Hz, 9H), 0.88 (s, 9H), 
0.83 (d, J 7.2 Hz, 3H), 0.62-0.55 (m, 12H), 0.06 (s, 3H), 0.06 (s, 3H); 
13
C NMR (125 MHz, 
CDCl3) δ 214.1, 159.2, 130.8, 129.5 (2H), 113.8 (2H), 79.0, 75.8, 75.4, 72.9, 71.4, 70.1, 69.4, 
64.7, 58.9, 55.3, 50.2, 47.9, 42.9, 41.0, 40.6, 33.3, 25.9 (3H), 24.7, 18.9, 18.2, 9.8, 9.4, 7.1 (3H), 
7.1 (3H), 6.0 (3H), 5.4 (3H), 3.5, −4.3, −4.7; HRMS (ES) m/z calcd for C47H88O8NaSi3 (M + 
Na)
+
: 887.5685; found: 887.5624. 
 
 (2R,4R,5S,6S,7R,10S,12R)-2-(tert-
Butyldimethylsilyloxy)-10-hydroxy-1,12-
dimethoxy-5,7-dimethyl-4,6-
bis(triethylsilyloxy)octadec-16-yn-8-one: To a solution of 0.30 g of ketone  (0.507 mmol) in 
5.75 mL of Et2O at ambient temperature was added 0.097 mL of 
i
Pr2NEt (0.557 mmol) and 
subsequently cooled to −78 °C.  To this solution was added 0.532 mL of Bu2BOTf (0.532 mmol 
of a 1M solution in CH2Cl2) dropwise via syringe.  The resulting solution was maintained at −78 
°C for 1 h, whereupon 0.110 g of aldehyde  (0.659 mmol in 3.0 mL of Et2O) was added via 
syringe pump over 1 h.  The reaction was maintained at −78 °C overnight.  A mixture of 1:6 pH 
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7 phosphate buffer:MeOH (2.0 mL) was added at −78 °C, and the reaction was allowed to warm 
to 0 °C, whereupon 4 mL of a 1:2 mixture of 30% H2O2 : MeOH was added to the reaction.  This 
mixture was then allowed to stir at ambient temperature for 1 h before diluting the mixture with 
10 mL of H2O and extracting with Et2O (3 x 20 mL).  The combined organic layers were washed 
with saturated aqueous NaHCO3 (40 mL), dried over MgSO4, filtered and concentrated under 
vacuum.  The crude oil was subjected to high vacuum overnight to remove any excess MeOH 
before purification by flash chromatography on silica gel (10% EtOAc in hexanes) yielded 0.307 
g (79.7%) of an approximately 4:1 mixture of diastereomers, as well as recovering 0.05 g (16%) 
of the ketone starting material.  [α]21
D
  −39 (c 0.52, CHCl3). IR (thin film): 3490, 2953, 1707, 
1460, 1249, 1111, 834, 739 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 4.23 (dd, J = 7.0, 1.5 Hz, 1H), 
4.21-4.17 (m, 1H), 3.95 (ddd, J = 9.0, 5.0, 1.5 Hz, 1H), 3.73 (d, J = 2.0 Hz, 1H), 3.72-3.67 (m, 
1H), 3.50-3.43 (m, 1H), 3.34 (s, 3H), 3.33 (s, 3H), 3.30 (dd, J = 10.0, 4.0 Hz, 1H), 3.26 (dd, J = 
9.5, 5.5 Hz, 1H), 2.72 (dq, J = 7.0, 2.0 Hz, 1H), 2.65 (dd, J = 17.0, 8.0 Hz, 1H), 2.57 (dd, J = 
16.5, 4.5 Hz, 1H), 2.16-2.13 (m, 2H), 1.77 (t, J = 2.5 Hz, 3H), 1.81-1.75 (m, 2H), 1.70-1.55 (m, 
4H), 1.55-1.48 (m, 2H), 1.25 (s, 1H), 1.08 (d, J = 7.0 Hz, 3H), 0.96 (t, J = 8.0 Hz, 9H), 0.94 (t, J 
= 8.0 Hz, 9H), 0.88 (s, 9H), 0.85 (d, J 7.0 Hz, 3H), 0.63-0.55 (m, 12H), 0.06 (s, 3H), 0.06 (s, 
3H); 
13
C NMR (125 MHz, CDCl3) δ 213.7, 80.3, 79.4, 77.8, 77.5, 76.4, 73.5, 70.8, 70.0, 67.7, 
59.9, 56.7, 51.0, 48.6, 43.6, 41.2, 40.7, 32.7, 26.5 (3C), 24.7, 19.5, 18.8, 10.1, 7.7 (3C), 7.6 (3C), 
6.6 (3C), 6.1(3C), 4.0, −3.7, −4.1; HRMS m/z calcd for C40H82O7NaSi3: 781.5266; found: 
781.5204. 
 
 (2S,3R,4S,5R,6R)-6-((R)-2-(tert-Butyldimethylsilyloxy)-
3-methoxypropyl)-2-((2S,4R)-2-hydroxy-4-(4-
methoxybenzyloxy)dec-8-ynyl)-2-methoxy-3,5-
dimethyltetrahydro-2H-pyran-4-ol:  To a 0 °C solution of 
0.060 g of ketone (0.07 mmol, 1.0 equiv) in 0.70 mL of 
CH2Cl2 and 0.70 mL of MeOH, was added 5.2 µL of 
CF3CO2H (0.07 mmol, 1.0 equiv) via syringe.  The reaction was allowed to stir at 0 °C for 5 
hours before the addition of 5 mL of saturated aqueous NaHCO3 and extracted with CH2Cl2 (3 x 
5 mL).  The combined organic fractions were combined and dried over Na2SO4, filtered, and 
concentrated.  The clear colorless oil was used crude in the following reaction. 
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 (2S,3R,4S,5R,6R)-6-[(R)-2-(tert-Butyldimethylsilyloxy)-
3-methoxypropyl]-2-[(2R,4R)-2-hydroxy-4-methoxydec-
8-ynyl]-2-methoxy-3,5-dimethyl-tetrahydro-2H-pyran-4-
ol: To a solution of 0.225 g of ketone (0.296 mmol) in 3.3 
mL of CH2Cl2 and 3.3 mL of MeOH at ambient temperature 
is added 11.1 mg of PPTS (0.044 mmol) as a solid.  The 
resulting mixture is maintained at ambient temperature for 12 h whereupon saturated aqueous 
NaHCO3 (10 mL) is added.  The mixture is diluted with H2O (5 mL), and extracted with Et2O (3 
x 20 mL), dried over Na2SO4, filtered and concentrated.  The crude oil was purified by flash 
chromatography on IATRO beads (20% EtOAc in hexanes) to yield 0.120 g (74.5%) of a clear 
colorless oil.  [α]23
D
  + 64 (c 0.35, CHCl3). IR (thin film): 3459, 2930, 1461, 1251, 1096, 985, 834, 
776 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 3.98 (dt, J = 8.5, 3.5 Hz, 1H), 3.95-3.87 (m, 4H), 3.36-
3.32 (m, 2H), 3.31 (s, 6H), 3.30-3.27 (m, 2H), 3.20 (s, 3H), 2.17-2.14 (m, 2H), 1.99-1.93 (m, 
1H), 1.88-1.83 (m, 2H), 1.81 (dd, J = 13.5, 7.0 Hz, 1H), 1.77 (t, J = 2.5 Hz, 3H), 1.74-1.69 (m, 
1H), 1.65-1.61 (m, 1H), 1.61-1.4- (m, 6H), 1.00 (d, J = 6.5 Hz, 3H), 0.92 (d, J = 6.5 Hz, 3H), 
0.87 (s, 9H), 0.06 (s, 3H), 0.05 (s, 3H); 
13
C NMR (75 MHz, CDCl3) δ 103.5, 79.0, 77.6, 77.4, 
75.7, 72.1, 69.6, 68.8, 64.8, 58.8, 56.1, 47.6, 41.4, 39.1, 38.7, 38.6, 36.5, 32.5, 25.9 (3C), 24.6, 
18.8, 18.2, 11.4, 4.9, 3.4, −3.8, −4.7; HRMS m/z calcd for C29H56O7NaSi: 567.3693; found: 
567.3659. 
 
 (2S,3R,4S,5S,6R)-2-((2S,4R)-2-(Benzoyloxy)-4-(4-
methoxybenzyloxy)dec-8-ynyl)-6-((R)-2-(tert-
butyldimethylsilyloxy)-3-methoxypropyl)-2-methoxy-
3,5-dimethyltetrahydro-2H-pyran-4-yl benzoate:  To an 
ambient temperature solution of 0.100 g of the diol (0.153 
mmol, 1.0 equiv) in 1.1 mL of pyridine was added 113 mg 
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of benzoyl bromide (0.614 mmol, 4.0 equiv).  The solution was heated to 50 °C for 1 hour.  The 
greenish mixture was quenched with water, and extracted with CH2Cl2 (3 x 10 mL).  The 
combined organic extracts were washed with 0.1N HCl (15 mL), and saturated aqueous NaHCO3 
(15 mL), then dried (Na2SO4), and concentrated.  The crude oil was purified by mPLC using a 
gradient elution from 2 to 12 % EtOAc in hexanes to yield 60 mg (46%) of a clear colorless oil.  
[α]23
D
  + 33.8 (c 2.62, CHCl3). IR (thin film): 3019, 1710, 1513, 1215, 756 cm
-1
; 
1
H NMR (500 
MHz, CDCl3) δ 8.03 (dd, J = 8.0, 1.0 Hz, 2H), 7.95 (dd, J = 8.0, 1.0 Hz, 2H), 7.60-7.52 (m, 2H), 
7.44 (dq, J = 7.5, 7.5 Hz, 4H), 7.30-7.27 (m, 2H), 6.82-6.78 (m, 2H), 5.57-5.51 (m, 1H), 5.27 
(dd, J = 11.5, 5.0 Hz, 1H), 4.48 (d, 11.0 Hz, 1H), 4.36 (d, J = 11.0 Hz, 1H), 4.0-3.91 (m, 2H), 
3.70 (s, 3H), 3.56-3.51 (m, 1H), 3.37 (dd, J = 9.5, 4.0 Hz, 1H), 3.35 (s, 3H), 10, 6.5 Hz, 1H), 
3.17 (s, 3H), 2.31-2.23 (m, 2H), 2.16-2.08 (m, 5H), 1.84-1.80 (m, 1H), 1.78 (t, 2.5 Hz, 3H), 1.75-
1.65 (m, 2H), 1.61-1.54 (m, 2H), 1.50-1.42 (m, 1H), 1.05 (d, J = 7.0 Hz, 3H), 0.88 (s, 12H), 0.07 
(s, 3H), 0.06 (s, 3H); 
13
C NMR (75 MHz, CDCl3) δ 166.0, 165.8, 158.9, 132.8, 132.7, 130.9, 
130.6, 130.5, 129.5, 129.5, 129.2, 128.3, 113.6, 101.6, 78.9, 77.6, 75.9, 75.7, 74.7, 70.8, 70.1, 
69.8, 68.0, 58.8, 55.1, 47.3, 40.3, 38.1, 36.1, 34.9, 33.0, 25.9, 24.1, 18.9, 18.2, 11.5, 5.9, 3.4, -
3.9, -4.6; HRMS m/z calcd for C50H70O10NaSi: 881.4636; found: 881.4636. 
 
 (2S,3R,4S,5R,6R)-6-((R)-2-(tert-Butyldimethylsilyloxy)-
3-methoxypropyl)-2-((2S,4R)-2-triethylsilyloxy-4-(4-
methoxybenzyloxy)dec-8-ynyl)-2-methoxy-3,5-
dimethyltetrahydro-2H-4-triethylsilyloxypyran (73):  To 
a −55 °C solution of 0.170 g of the diol (0.261 mmol, 1.0 
equiv) in 1.8 mL of CH2Cl2 was added 0.182 mL of 2,6-
lutidine (1.56 mmol, 6.0 equiv), followed by 0.147 mL of TESOTf (0.652 mmol, 2.5 equiv).  
The reaction was allowed to stir for 12 h at −55 °C.  Saturated aqueous NaHCO3 (5 mL) was 
added, and the mixture was extracted with CH2Cl2 (3 x 10 mL).  The combined organic layers 
were dried over Na2SO4, filtered, and concentrated.  The crude mixture was purified via flash 
chromatography with silica gel (10% EtOAc/Hexanes) to yield 0.223 g (95%, 2 steps) of a clear 
colorless oil.  [α]21
D
  +32.8 (c 0.79, CHCl3). IR (thin film): 1613, 1513, 1460, 1247, 1066 cm
-1
; 
1
H 
NMR (600 MHz, CDCl3) δ 7.24 (d, J = 9 Hz, 2H), 6.84 (d, J = 8.4 Hz, 2H), 4.50 (d, J = 10.8 Hz, 
1H), 4.35 (d, J = 11.4 Hz, 1H), 4.01-3.96 (m, 1H), 3.92-3.87 (m, 1H), 3.93-3.78 (m, 5H), 3.56 
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(App. dq, J = 8.4, 4.8 Hz, 1H), 3.37 (dd, J = 9.6, 3.6 Hz, 1H), 3.32 (s, 3H), 2.19 (ddd, J = 14.4, 
8.4, 3.6 Hz, 1H), 2.15-2.10 (m, 2H), 1.89 (dd, J = 13.8, 9.0 Hz, 1H), 1.77 (t, J = 2.4 Hz, 3H), 
1.77-1.57 (m, 6H), 1.55-1.50 (m, 2H), 1.38 (App. dtd, J = 14.4, 7.2, 3.0 Hz, 2H), 0.97-0.91 (m, 
21H), 0.87 (s, 9H), 0.84 (d, J = 6.6 Hz, 3H), 0.62-0.53 (m, 12H), 0.06 (s, 6H); 
13
C NMR (150 
MHz, CDCl3) δ 158.7, 131.5 (2C), 128.6 (2C), 113.5, 101.7, 79.2, 77.8, 75.5, 75.4, 73.0, 70.3, 
69.6, 68.2, 67.0, 58.7, 55.2, 47.0, 43.3, 42.2, 40.1, 38.6, 37.0, 33.0, 26.0 (3C), 24.1, 19.0, 18.2, 
12.3, 7.0 (3C), 6.9 (3C), 5.5, 5.3 (3C), 5.1 (3C), 3.5, −3.8, −4.7; HRMS (ES) m/z calcd for 
C48H90O8NaSi3 (M + Na)
+
: 901.5841; found: 901.5911. 
 
 
 (2S,3R,4S,5R,6R)-6-((R)-2-(tert-Butyldimethylsilyloxy)-
3-methoxypropyl)-2-((2S,4R)-2-triethylsilyloxy-4-(4-
hydroxy)dec-8-ynyl)-2-methoxy-3,5-dimethyltetrahydro-
2H-4-triethylsilyloxypyran:  To a solution of 0.150 g of 
PMB ether (0.17 mmol, 1.0 equiv) at 0 °C in 5 mL of a 2:1 
mixture of CH2Cl2:pH 7 phosphate buffer was added 0.058 
g of DDQ (0.25 mmol, 1.5 equiv).  The mixture was stirred for 2.5 hours at 0 °C.  A saturated 
aqueous solution of NaHCO3 (5 mL) was added, and the resulting mixture was extracted with 
CH2Cl2 (3 x 10 mL).  The combined organic layers were passed through a plug of celite before 
concentration.  The crude oil was purified via flash chromatography on IATRO
®
 beads with 7% 
EtOAc/Hexanes to yield 117 mg (90.7%) of a clear colorless oil.  [α]21
D
  +60.3 (c 0.19, CHCl3). IR 
(thin film): 3519, 1460, 1247, 1068, 1005 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 4.15-4.14 (m, 
1H), 4.11-4.05 (m, 1H), 3.92 (App. s, 1H), 3.91-3.87 (m, 1H), 3.87-3.82 (m, 2H), 3.34-3.31 (m, 
4H), 3.25 (dd, J = 9.6, 6.0 Hz, 1H), 3.15 (s, 3H), 2.30 (dd, J = 13.8, 10.2 Hz, 1H), 2.17-2.12 (m, 
2H), 1.82-1.78 (m, 1H), 1.76 (t, J = 3 Hz, 3H), 1.73 (dd, J = 14.4, 3.6 Hz, 1H), 1.70-1.63 (m, 
3H), 1.60-1.53 (m, 2H), 1.51-1.37 (m, 3H), 0.98-0.93 (m, 21H), 0.87 (s, 9H), 0.83 (d, J = 6.6 Hz, 
3H), 0.63-0.57 (m, 12H), 0.05 (s, 6H); 
13
C NMR (150 MHz, CDCl3) δ 101.5, 79.1, 77.7, 75.6, 
72.8, 70.0, 69.3, 68.2, 68.0, 58.7, 47.2, 41.3, 40.0, 39.2, 38.7, 37.3, 37.0, 26.0 (3C), 25.1, 19.0, 
18.2, 12.2, 6.9 (3C), 6.8 (3C), 5.6, 5.0 (3C), 4.7 (3C), 3.5, −3.7, −4.7; HRMS (ES) m/z calcd for 
C40H82O7NaSi3 (M + Na)
+
: 781.5266; found: 781.5277. 
 
 73 
 (2S,3R,4S,5S,6R)-2-((2S,4R)-2-(Benzoyloxy)-4-
methoxydec-8-ynyl)-6-((R)-2-(tert-
butyldimethylsilyloxy)-3-methoxypropyl)-2-methoxy-
3,5-dimethyltetrahydro-2H-pyran-4-yl benzoate:  To a 0 
°C solution of 60 mg of the pmb ether (0.07 mmol, 1.0 
equiv) in 2 mL of 1:2 mixture of pH 7 buffer:DCM was 
added 23.7 mg of DDQ (0.104 mmol, 1.5 equiv), and the reaction was stirred for 2.5 hours.  The 
reaction was quenched with saturated aqueous NaHCO3, and extracted with CH2Cl2 (3 x 10 mL).  
The organic extracts were passed through a plug of celite, concentrated.  The crude oil was taken 
up in 0.7 mL of CH2Cl2, and to this solution was added 45 mg of proton sponge (0.21 mmol, 3.0 
equiv), followed by 31 mg of Me3OBF3 (0.21 mmol, 3.0 equiv) at ambient temperature.  Upon 
completion the reaction was quenched with saturated aqueous ammonium chloride, and extracted 
with CH2Cl2 (3 x 5 mL).  Wash the combined organic extracts with 1M NaHSO4 (10 mL), then 
dried (Na2SO4), and concentrate.  The crude mixture was purified via flash chromatography with 
silica gel (10 to 20% EtOAc/Hexanes) to yield 40 mg (76%, 2 steps) of a clear colorless oil.  
[α]21
D
  + 83.6 (c 0.33, CHCl3). IR (thin film): 3019, 1642, 1215, 753 cm
-1
; 
1
H NMR (500 MHz, 
CDCl3) δ 8.07-8.05 (m, 2H), 7.98-7.96 (m, 2H), 7.60-7.52 (m, 2H), 7.48-7.39 (m, 4H), 5.48-5.45 
(m, 1H), 5.27 (dd, J = 11.0, 4.5 Hz, 1H), 3.99-3.94 (m, 2H), 3.38 (dd, J = 9.5, 4.0 Hz, 1H), 3.35 
(s, 3H), 3.31 (s, 3H), 3.30-3.26 (m, 1H), 3.19 (s, 3H), 2.32-2.26 (m, 1H), 2.17-2.04 (m, 6H), 
1.81-1.76 (m, 2H), 1.75 (t, J = 2.5 Hz, 3H), 1.65-1.59 (m, 3H), 1.56-1.45 (m, 3H), 1.03 (d, J = 
7.0 Hz, 3H), 0.91 (d, J = 7.0 Hz, 3H), 0.88 (s, 9H), 0.07 (s, 3H), 0.06 (s, 3H); 
13
C NMR (125 
MHz, CDCl3) δ 166.0, 165.8, 132.8, 132.7, 130.6, 130.5, 129.5, 129.5, 128.3, 128.2, 101.6, 78.8, 
75.9, 75.7, 70.2, 69.8, 67.9, 58.8, 56.9, 47.3, 40.3, 38.1, 38.0, 36.1, 35.0, 32.8, 25.9, 24.2, 18.9, 
18.2, 11.6, 5.8, 3.4, -3.9, -4.6; HRMS (ES) m/z calcd for C43H64O9NaSi  (M + Na)
+
: 775.4217; 
found: 775.4238. 
 
 (2S,3R,4S,5R,6R)-6-((R)-2-(tert-Butyldimethylsilyloxy)-
3-methoxypropyl)-2-methoxy-2-((2S,4R)-4-methoxy-2-
(triethylsilyloxy)dec-8-ynyl)-3,5-dimethyltetrahydro-2H-
4-triethylsilyloxy-pyran (74):  To a solution of 382 mg of 
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the alcohol (0.503 mmol, 1.0 equiv) in 5.2 mL of CH2Cl2 at ambient temperature was added 323 
mg of H
+
 Sponge
®
 (1.51 mmol, 3.0 equiv) and 223 mg of Me3OBF4 (1.51 mmol, 3.0 equiv), 
sequentially.  The solution was then stirred at ambient temperature for 1.5 hr, before 
approximately 5 mL of saturated aqueous NH4Cl was added, and the layers were separated.  The 
aqueous layer was extracted with CH2Cl2 (3 x 10 mL).  The organic layers were combined and 
washed with 20 mL of 1M NaHSO4, dried over Na2SO4, filtered, and concentrated.  The crude 
oil was passed through a short plug of silica gel with 20% EtOAc in Hexanes, and concentrated, 
to yield 382 mg (98%) of a the title compound as a clear colorless oil.  [α]22
D
  +36 (c 0.93, CHCl3). 
IR (thin film): 2953, 1460, 1247, 1067 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 3.97 (app. dtd, J = 
2.7, 8.2 Hz, 1H), 3.91 (app. dtd, J = 4.2, 7.2 Hz, 1H), 3.83-3.78 (m, 2H), 3.37 (dd, J = 3.6, 9.6 
Hz, 1H), 3.36-3.32 (m, 1H), 3.32 (s, 3H), 3.28-3.23 (m, 2H), 3.26 (s, 3H), 3.11 (s, 3H), 2.15-2.12 
(m, 2H), 2.05 (ddd, J = 3.6, 9.6, 12 Hz, 1H), 1.90 (dd, J = 9.0, 13.8 Hz, 1H), 1.77 (t, 2.4 Hz, 3H), 
1.75-1.71 (m, 2H), 1.68-1.60 (m, 2H), 1.50-1.46 (m, 2H), 1.40 (ddd, J = 2.4, 7.2, 13.8 Hz, 1H), 
1.32-1.28 (m, 1H), 0.96 (app. dt, J = 2.4, 7,8 Hz, 21H), 0.88 (s, 9H), 0.86 (d, J = 6.6 Hz, 3H), 
0.63-0.58 (m, 12H), 0.06 (s, 6H); 
13
C NMR (150 MHz, CDCl3) δ 101.7, 79.1, 77.9, 76.6, 73.1, 
70.3, 68.2, 66.7, 58.7, 55.6, 47.1, 43.0, 42.2, 40.1, 38.7, 36.9, 32.3, 31.6, 26.0 (3H), 24.0, 19.0, 
18.2, 12.4, 7.0 (3H), 6.9 (3H), 5.3 (3H), 5.0 (3H), 3.5, −3.8, −4.7; HRMS (ES) m/z calcd for 
C41H84O7NaSi3 (M + Na)
+
: 795.5423; found: 795.5435. 
 
 (2S,3R,4S,5R,6R)-6-[(R)-2-(tert-Butyldimethylsilyloxy)-
3-methoxypropyl]-2-methoxy-2-[(2R,4R)-4-methoxy-2-
(triethylsilyloxy)dec-8-ynyl]-3,5-dimethyltetrahydro-4-
(triethylsilyloxy)-2H-pyran (57): To a −55 °C solution of 
0.767 g of hemi-ketal 56 (0.140 mmol) in 0.5 mL of CH2Cl2 
is added 0.098 mL of 2,6-lutidine (0.84 mmol) followed by 
0.079 mL of TESOTf (0.35 mmol) slowly via syringe.  The resulting solution was maintained at 
−55 °C for 3 h.  Saturated aqueous NaHCO3 (1 mL) was added and the mixture was extracted 
with CH2Cl2 (3 x 5 mL).  The combined organic extracts were dried over Na2SO4, filtered and 
concentrated.  Purification of the crude oil by flash chromatography on silica gel (5% EtOAc in 
hexanes) afforded 0.106 g (98%) of a clear colorless oil.  [α]21
D
  +63 (c 0.33, CHCl3). IR (thin 
film): 2953, 1460, 1246, 1069, 1008, 835, 741 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 3.95-3.92 (m, 
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1H), 3.91-3.86 (m, 1H), 3.85-3.83 (m, 1H), 3.77 (dd, J = 10.5, 5.0 Hz, 1H), 3.33-3.30 (m, 1H), 
3.32 (s, 3H), 3.30 (s, 3H), 3.26 (dd, J = 9.5, 6.0 Hz, 1H), 3.12 (s, 3H), 2.16-2.11 (m, 2H), 1.97 (d, 
J = 14.5 Hz, 1H), 1.84-1.80 (m, 2H), 1.77 (t, J = 2.5 Hz, 3H), 1.70-1.63 (m, 4H), 1.58-1.45 (m, 
4H), 1.45-1.40 (m, 2H), 0.97 (t, J = 8.0 Hz, 9H), 0.95 (t, J = 8.0 Hz, 9H), 0.90 (d, J = 7.0 Hz, 
3H), 0.88 (s, 9H), 0.87 (d, J = 7.2 Hz, 3H), 0.70-0.56 (m, 12H), 0.07 (s, 3H), 0.06 (s, 3H); 
13
C 
NMR (125 MHz, CDCl3) δ 102.2, 79.1, 77.9, 77.8, 75.5, 73.2, 69.8, 67.8, 66.7, 58.7, 56.2, 47.2, 
42.9, 41.9, 39.9, 38.6, 37.6, 32.8, 25.9 (3C), 24.7, 18.9, 18.2, 12.2, 7.0 (3C), 6.9 (3C), 5.3, 5.1 
(3C), 5.0 (3C), 3.4, −3.7, −4.7; HRMS m/z calcd for C41H84O7NaSi3: 795.5423; found: 795.5399. 
 
 
 (2S,3R,4S,5R,6R)-6-((R)-2-(tert-
Butyldimethylsilyloxy)-3-methoxypropyl)-2-
((2S,4R,E)-9-iodo-4-methoxy-2-
(triethylsilyloxy)dec-8-enyl)-2-methoxy-3,5-
dimethyltetrahydro-2H-4-triethylsilyloxypyran 
(75):  In a flame dried vessel was placed 100 mg of 
Cp2ZrHCl (0.388 mmol, 3.0 equiv) under vacuum for 1 hour before the addition of 100 mg of the 
alkyne (0.129 mmol, 1.0 equiv) in 1.30 mL of THF.  The heterogeneous reaction was stirred at 
50° C for 30 minutes before being cooled to 0° C.  At this point 45 µL of 2,6-lutidine (0.388 
mmol, 3.0 equiv) was added, followed by 98 mg of I2 (0.388 mmol, as a solution in 0.5 mL of 
THF, 3.0 equiv), which was added dropwise.  The opaque tan mixture turned yellow upon 
addition of approximately half of the I2, and a dark purple/brown after complete addition.  This 
mixture was allowed to stir at 0° C for 10 minutes before the addition of approximately 2 mL of 
saturated aqueous Na2S2O3, at which time the reaction turned a pale, clear yellow color.  The 
mixture was partitioned between Et2O and H2O (5 mL each), separated and extracted with Et2O 
(3 x 10 mL).  The organic layers were combined, and passed through a plug of silica gel before 
concentrating to a clear colorless oil.  The crude oil was purified by flash column 
chromatography on silica gel (3% EtOAc in hexanes) to yield 77 mg (72%) of a clear colorless 
oil.  Product had >17:1 regioselectivity after chromatography, as assayed by 500 MHz 
1
H NMR.  
[α]22
D
  + 32.1 (c 1.14, CHCl3). IR (thin film): 1635, 1460, 1381, 1246, 1065, 836 cm
-1
; 
1
H NMR 
(500 MHz, CDCl3) δ 6.15 (App. td, J = 7.5, 1.5 Hz, 1H), 3.99-3.95 (m, 1H), 3.95-3.88 (m, 1H), 
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3.83-3.78 (m, 2H), 3.37-3.33 (m, 2H), 3.33 (s, 3H), 3.28-3.23 (m, 4H), 3.12 (s, 3H), 2.36 (s, 3H), 
2.07-2.00 (m, 2H), 1.89 (dd, J = 14.0, 9.0 Hz, 1H), 1.77-1.71 (m, 2H), 1.70-1.62 (m, 2H), 1.52-
1.36 (m, 5H), 1.32-1.24 (m, 2H), 0.99-0.93 (m, 21H), 0.88 (s, 9H), 0.86 (d, J = 7.0 Hz, 3H), 
0.64-0.56 (m, 12H), 0.06 (s, 6H); 
13
C NMR (75 MHz, CDCl3) δ 141.2, 101.7, 93.6, 77.9, 73.1, 
70.2, 68.1, 66.7, 58.8, 55.7, 47.1, 43.0, 42.2, 40.1, 38.8, 36.9, 32.5, 30.8, 27.5, 25.9 (3C), 23.9, 
18.2, 12.4, 7.0 (3C), 6.9 (3C), 5.4, 5.3 (3C), 5.0 (3C), −3.7, −4.7; HRMS (ES) m/z calcd for 
C41H85O7NaSi3I (M + Na)
+
: 923.4546; found: 923.4515. 
 
(2E,4E,6E,8R,9R,10E,12E,17R,19S)-ethyl 20-
((2S,3R,4S,5S,6R)-6-((R)-2-(tert-
Butyldimethylsilyloxy)-3-methoxypropyl)-2-
methoxy-3,5-dimethyl-4-
(triethylsilyloxy)tetrahydro-2H-pyran-2-yl)-9-
hydroxy-17-methoxy-2,4,6,8,12-pentamethyl-19-
(triethylsilyloxy)icosa-2,4,6,10,12-pentaenoate 
(77): 
To a flame dried vessel was added 0.151 g of vinyl stannane (0.266 mmol, 4 equiv), and 0.060 g 
of vinyl iodide (0.066 mmol, 1.0 equiv).  The mixture was subjected to high vacuum for one 
hour before refilling the vessel with N2(g).  To this was added 1.3 mL of degassed DMF at 
ambient temperature, before adding 0.152 g of Ph2PO2NBu4 (0.332 mmol, 5 equiv).  The vessel 
was opened to atmosphere momentarily to add 1.7 mg of Pd2Cl2(MeCN)2 (0.0066 mmol, 0.1 
equiv).  The reaction mixture immediately turned black.  The reaction was covered in foil and 
stirred at ambient temperature for 15 hours before being quenched with 13.0 mL of a 1:1 solution 
of Et2O to hexanes.  This heterogeneous mixture was passed through a plug of celite, rinsing 
with more of the same 1:1 solution.  The yellowish organic eluent was washed with brine (3 x 20 
mL) before being dried (Na2SO4), and concentrated.  The crude yellow oil was purified by flash 
chromatography (10 % EtOAc/Hex) affording 48 mg (75%) of the title compound as a 12:1 
mixture of isomers as assayed by 500 MHz 
1
H NMR.    [α]22
D
  +54.7 (c 0.19, CHCl3). IR (thin 
film): 2925, 1705, 1460, 1376, 1250, 1068, 1004 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.15 (s, 
1H), 6.22 (d, J = 15.5 Hz, 1H), 6.01 (s, 1H), 5.57 (dd, J = 15.5, 7.0 Hz, 1H), 5.47 (t, J = 7.0 Hz, 
1H), 5.27 (d, J = 10.0 Hz, 1H), 4.18 (q, J = 5.0 Hz, 2H), 4.05-4.02 (m, 1H), 3.98-3.94 (m, 1H), 
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3.93-3.88 (m, 1H), 3.83-3.77 (m, 2H), 3.38-3.29 (m, 5H), 3.26-3.22 (m, 4H), 3.10 (s, 3H), 2.70-
2.65 (m, 1H), 2.16-2.10 (m, 2H), 2.02 (s, 3H), 1.96 (s, 3H), 1.92-1.86 (m, 1H), 1.79 (s, 3H), 
1.76-1.70 (m, 4H), 1.66-1.61 (m, 3H), 1.50-1.44 (m, 2H), 1.42-1.32 (m, 4H), 1.31-1.24 (m, 5H), 
1.05 (d, J = 6.5 Hz, 3H), 0.98-0.90 (m, 21H), 0.88 (s, 9H), 0.86 (d, J = 7.0 Hz, 3H), 0.63-0.57 (m, 
12H), 0.06 (s, 6H); 
13
C NMR (75 MHz, CDCl3) δ 169.3, 143.6, 138.9, 136.5, 133.7, 133.4, 132.9 
(2C), 131.8, 136.9, 125.9, 101.7, 77.8, 73.0, 70.2, 68.2, 66.7, 60.6, 58.7, 55.6, 47.0, 43.0, 40.0, 
39.4, 36.9, 32.8, 28.4, 27.8, 26.8, 25.9 (3C), 24.5, 18.2, 17.5, 17.3, 16.5, 14.3, 14.1, 13.6, 12.5, 
12.3, 7.0 (3C), 6.9 (3C), 5.4, 5.31 (3C), 5.3 (3C), −3.8, −4.7; HRMS (ES) m/z calcd for 
C58H110O10NaSi3 (M + Na)
+
: 1073.7305; found: 1073.7268. 
 
 (2E,4E,6E,8R,9R,10E,12E,17R,19S)-20-
((2S,3R,4S,5R,6R)-6-((R)-2-(tert-
Butyldimethylsilyloxy)-3-methoxypropyl)-4-
hydroxy-2-methoxy-3,5-dimethyltetrahydro-2H-
pyran-2-yl)-9,19-dihydroxy-17-methoxy-2,4,6,8,12-
pentamethylicosa-2,4,6,10,12-pentaenoic acid:  The 
mixture of protected seco-acid (52 mg, 0.0572 mmol, 
1.0 equiv) was added to 8.34 mL of a 1:1 mixture of 
MeOH and CH2Cl2.  The solution was cooled to −15° C in a MeOH and ice bath.  4.3µL (0.0572 
mmol, 1.0 equiv) of CF3CO2H dissolved in 0.6 mL of CH2Cl2 and added dropwise.  The solution 
was maintained at −15° C for 30 minutes before being quenched with sat. aq. NaHCO3 (10 mL).  
The aqueous layer was extracted with EtOAc (3 x 20 mL), the combined organic layers were 
dried over Na2SO4, concentrated, and purified by flash column (5% MeOH/CH2Cl2), to yield 
26.5 mg (58%) of the seco-acid which was combined with the purified material from the 
previous step, giving an overall yield of 33.5 mg (48% over two steps). 
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 (3E,5E,7E,9R,10R,11E,13E,18R,20S)-20-
(((2S,3R,4S,5R,6R)-6-((R)-2-(tert-
Butyldimethylsilyloxy)-3-methoxypropyl)-4-
hydroxy-2-methoxy-3,5-dimethyltetrahydro-2H-
pyran-2-yl)methyl)-10-hydroxy-18-methoxy-
3,5,7,9,13-pentamethyloxacycloicosa-3,5,7,11,13-
pentaen-2-one:  To an ambient temperature solution 
of 25.0 mg of seco-acid (0.0314 mmol, 1.0 equiv) in 
7.44 mL of THF was added 0.174 mL of NEt3 (1.25 mmol, 4.0 equiv), followed by 19.5 µL of 
2,4,6-trichlorobenzoyl chloride (0.125 mmol, 40.0 equiv) dropwise.  The reaction was stirred in a 
foil-covered flask at ambient temperature for 15 hours, whereupon it was diluted with 7.44 mL 
of toluene, and added to 930 mL of toluene containing 0.767 g of DMAP (6.28 mmol, 200 
equiv).  The addition took place via syringe pump over 1 hour [followed by two rinses of toluene 
(1.0 and 0.5 mL) added over 20 and 10 minutes respectively].  The reaction was then allowed to 
stir at ambient temperature for 24 hours, covered in foil, before being concentrated to 
approximately 200 mL via rotovap.  The toluene solution was then quenched with NH4Cl (200 
mL) and extracted with EtOAc (3 x 200 mL).  The combined organic layers were dried with 
Na2SO4, filtered, and concentrated.  The crude mixture was purified by flash column 
chromatography on IATRO beads with 2% MeOH in CH2Cl2 yielding 13.9 mg (57%) of the 
desired lactone based on HMQC, HMBC, and cosy correlations.  The reaction also yielded 2.0 
mg (8%) of a minor product believed to be macrolactonization on the pyran oxygen. [α]21
D
  +10.2 
(c 0.23, CHCl3). IR (thin film): 3409, 2925, 1693, 1460, 1384, 1248, 1096 cm
-1
; 
1
H NMR (500 
MHz, CDCl3) δ 7.36 (d, J = 4.2 Hz, 1H), 7.11 (s, 1H), 6.08 (app. d, J = 15 Hz, 1H), 6.07 (app. s, 
1H), 5.51 (app. t, J = 7.2 Hz, 1H), 5.34 (dd, J = 15.6, 8.4 Hz, 1H), 5.13 (d, J = 9.6 Hz, 1H), 5.04 
(app. t, J = 10.2 Hz, 1H), 3.95-3.89 (m, 2H), 3.86-3.81 (m, 2H), 3.37 (dd, J = 10.2, 4.2 Hz, 1H), 
3.35 (s, 3H), 3.33-3.28 (m, 1H), 3.27 (s, 3H), 3.12 (s, 3H), 2.92 (br. q, J = 7.2 Hz, 1H), 2.55-2.50 
(m, 1H), 2.27-2.21 (m, 1H), 2.12 (s, 3H), 2.10 (app. d, J = 5.4 Hz, 1H), 2.07 (s, 3H), 2.10-1.90 
(m, 3H), 1.88 (s, 3H), 1.86-1.80 (m, 2H), 1.78-1.72 (m, 2H), 1.67-1.63 (m, 4H), 1.46 (ddd, J = 
14.4, 7.2, 3.6 Hz, 2H), 1.39 (app. d, J = 5.4 Hz, 1H), 1.35-1.25 (m, 2H), 1.14 (d, J = 6.6 Hz, 3H), 
1.11 (d, J = 6.6 Hz, 3H), 0.91 (d, J = 6.6 Hz, 3H), 0.87 (s, 9H), 0.06 (s, 3H), 0.06 (s, 3H); 
13
C 
NMR (75 MHz, CDCl3) δ 168.7, 145.1, 144.5, 140.3, 137.3, 133.0, 132.8, 132.1, 131.8, 128.3, 
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128.2, 127.1, 123.8, 101.5, 79.7, 79.0, 77.8, 72.4, 70.6, 70.0, 68.5, 58.8, 57.3, 47.2, 41.3, 39.5, 
38.9, 38.4, 37.0, 33.5, 29.7, 28.0, 26.7, 25.9 (3C), 18.2, 17.5, 17.3, 16.3, 13.7, 12.0, 11.3, 4.9,  
−3.8, −4.7; HRMS (ES) m/z calcd for C44H76O9SiNa (M + Na)
+
: 799.5156; found: 799.5152. 
 
 (3E,5E,7E,9R,10R,11E,13E,18R,20S)-20-
(((2S,3R,4S,5R,6R)-2,4-Dihydroxy-6-((R)-2-
hydroxy-3-methoxypropyl)-3,5-
dimethyltetrahydro-2H-pyran-2-yl)methyl)-10-
hydroxy-18-methoxy-3,5,7,9,13-
pentamethyloxacycloicosa-3,5,7,11,13-pentaen-2-
one, (Apoptolidinone) (78):  Protected aglycone (3.0 
mg; 0.00386 mmol, 1.0 equiv) was dissolved in 0.55 
mL of acetonitrile and cooled to −35° C in a refrigerator.  To this solution was added ~14 mg of 
H2SiF6 (~60 mg of a 20-25% solution in H2O; 0.0965 mmol, 25 equiv.; measured as 6 drops 
from a 20 gauge needle).  The solution remained in the refrigerator for 40 hours before being 
quenched at −35° C with 0.100 mL of NEt3.  The resulting mixture was allowed to sit for 30 
minutes at −35° C before quenching with sat. aq. NaHCO3 (1 mL) and extracting with EtOAc (5 
x 1.0 mL).  The organic layer was combined and dried over Na2SO4, before being purified by 
flash chromatography (5% MeOH/CH2Cl2 on IATRO beads), yielding 0.7 mg (30%) of the 
aglycone as a white solid.  [α]21
D
  + (c, CHCl3). IR (thin film): cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 
7.36 (d, J = 4.2 Hz, 1H), 7.11 (s, 1H), 6.08 (app. d, J = 15 Hz, 1H), 6.07 (app. s, 1H), 5.51 (app. 
t, J = 7.2 Hz, 1H), 5.34 (dd, J = 15.6, 8.4 Hz, 1H), 5.13 (d, J = 9.6 Hz, 1H), 5.04 (app. t, J = 10.2 
Hz, 1H), 3.95-3.89 (m, 2H), 3.86-3.81 (m, 2H), 3.37 (dd, J = 10.2, 4.2 Hz, 1H), 3.35 (s, 3H), 
3.33-3.28 (m, 1H), 3.27 (s, 3H), 3.12 (s, 3H), 2.92 (br. q, J = 7.2 Hz, 1H), 2.55-2.50 (m, 1H), 
2.27-2.21 (m, 1H), 2.12 (s, 3H), 2.10 (app. d, J = 5.4 Hz, 1H), 2.07 (s, 3H), 2.10-1.90 (m, 3H), 
1.88 (s, 3H), 1.86-1.80 (m, 2H), 1.78-1.72 (m, 2H), 1.67-1.63 (m, 4H), 1.46 (ddd, J = 14.4, 7.2, 
3.6 Hz, 2H), 1.39 (app. d, J = 5.4 Hz, 1H), 1.35-1.25 (m, 2H), 1.14 (d, J = 6.6 Hz, 3H), 1.11 (d, J 
= 6.6 Hz, 3H), 0.91 (d, J = 6.6 Hz, 3H), 0.87 (s, 9H), 0.06 (s, 3H), 0.06 (s, 3H); 
13
C NMR (75 
MHz, CDCl3) δ,  −3.8, −4.7; HRMS (ES) m/z calcd for C37H60O9Na (M + Na)
+
: 671.4135; 
found: 671.4108. 
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 (2R,3R,4S)-2-(Benzyloxy)-1-(tert-butyldimethylsilyloxy)-4-methoxy-
5-methylhex-5-en-3-ol (90): To a −25 °C solution of 4.38 g of 
magnesium bromide diethyl etherate (17.0 mmol, 1.0 equiv) in 38.3 mL 
of CH2Cl2 was added 5.01 g of aldehyde 91 (17.0 mmol, 1.0 equiv).  The mixture was allowed to 
stir for 20 minutes at temperature, before the addition of 7.02 g of stannane 92 (18.7 mmol, 1.1 
equiv).  The mixture was covered, and allowed to warm slowly over 4-5 hours before being 
placed in a +4 °C cold room to stir for 12 hours.  The reaction was quenched with H2O (25 mL), 
and the mixture was extracted with CH2Cl2 (3 x 50 mL).  The combined organic extracts were 
dried (Na2SO4) and concentrated.  The resulting crude oil was a mixture of diastereomers (~3:1) 
which was purified by column chromatography (40 % EtOAc in hexanes on silica gel) to afford 
4.12 g (63 %) of the title compound as a single diastereomer.  [α]
22
D
  + 3.23 (c 1.30, CHCl3). IR 
(thin film): 3019, 1215, 757 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.35-7.27 (m, 5H), 5.04 (t, J = 2 
Hz, 1H), 4.88 (s, 1H), 4.72 (d, J = 11.5 Hz, 1H), 4.51 (d, J = 11.5 Hz, 1H), 3.83 (dd, J = 10.0, 7.0 
Hz, 1H), 3.81-3.76 (m, 2H), 3.74 (d, J = 8.0 Hz, 1H), 3.44 (ddd, J = 7.0, 5.5, 2.0 Hz, 1H), 3.26 (s, 
3H), 2.62 (d, 4.0 Hz, 1H), 1.66 (s, 3H), 0.89 (s, 9H), 0.06 (s, 3H), 0.05 (s, 3H); 
13
C NMR (125 
MHz, CDCl3) δ 141.8, 138.6, 128.3, 127.8, 127.6, 116.7, 86.4, 78.6, 73.0, 71.2, 62.0, 56.3, 25.8, 
18.2, 16.9, -5.4, -5.5; HRMS m/z calcd for C21H36O4NaSi: 403.2281; found: 403.2294. 
 
 (2R,3R,4S)-2-(Benzyloxy)-1-(tert-butyldimethylsilyloxy)-3-
(triethylsilyloxy)-4-methoxy-5-methylhex-5-en (93):  To a −45 °C 
solution of 4.12 g of alcohol 92 (10.8 mmol, 1.0 equiv) in 40.0 mL of 
CH2Cl2 was added 2.51 mL of 2,6-lutidine (2.31 g, 21.6 mmol, 2.0 equiv), followed by 3.73 mL 
of triethylsilyl triflate (4.29 g, 16.25 mmol, 1.5 equiv).  The reaction was allowed to proceed at 
temperature for 1 hour before being quenched with saturated aqueous sodium bicarbonate (40 
mL), and the mixture was extracted with CH2Cl2 (3 x 80 mL).  The combined organic extracts 
were washed with 1M NaHSO4 (100 mL), then dried (Na2SO4) and concentrated.  The resulting 
crude oil was purified by column chromatography (10 % EtOAc in hexanes on silica gel) to 
afford 5.34 g (100 %) of the title compound.  [α]22
D
  + 10.4 (c 0.67, CHCl3). IR (thin film): 3428 
(br), 2929, 1461, 1097, 838 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.34-7.30 (m, 5H), 5.00 (t, J = 
2.0 Hz, 1H), 4.93 (s, 1H), 4.64 (d, J = 12.0 Hz, 1H), 4.56 (d, J = 12.0 Hz, 1H), 3.88 (dd, J = 7.0, 
 81 
2.5 Hz, 1H), 3.74 (dd, J = 10.0, 6.0 Hz, 1H), 3.73 (t, J = 7.5 Hz, 1H), 3.60 (dd, J = 10.5, 6.0 Hz, 
1H), 3.33 (dt, J = 6.5, 3.0 Hz, 1H), 3.18 (s, 3H), 1.64 (s, 3H), 0.94 (t, J = 8.0 Hz, 9H), 0.87 (s, 
9H), 0.65-0.55 (m, 6H), 0.00 (3H), -0.01 (3H); 
13
C NMR (125 MHz, CDCl3) δ 142.3, 139.3, 
128.1, 127.6, 127.3, 115.8, 86.6, 80.6, 72.9, 61.9, 55.9, 25.8, 18.1, 17.3, 7.0, 5.3, -5.43, -5.44; 
HRMS m/z calcd for C27H50O4NaSi2: 517.3145; found: 517.3149. 
 
 (3R,4S,5R)-5-(Benzyloxy)-6-(tert-butyldimethylsilyloxy)-4-
(triethylsilyloxy)-3-methoxyhexan-2-one (93):  To a −78 °C solution of 
4.14 g of alkene 90 (8.36 mmol, 1.0 equiv) in 62.0 mL of CH2Cl2 and 6.2 
mL of MeOH was bubbled O3 until the solution became blue.  Upon color change, O2 was 
bubbled until clear, followed by bubbling N2 for 20 minutes.  To the solution at −78 °C was 
added 31 mL of Me2S, and was allowed to stir at temperature for 4 hours.  The solution was then 
warmed to ambient temperature and stirred for an additional hour.  TLC showed only a single 
product spot, and the solvent was removed in vacuo.  The crude oil was combined with other 
material from similar reactions run at different scales, and purified by column chromatography 
(10 % EtOAc in hexanes on silica gel) to afford 4.67 g (87 %) of the title compound.  [α]22
D
  +13.9 
(c 2.92, CHCl3). IR (thin film): 3019, 1215, 1092, 755 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.34-
7.30 (m, 5H), 4.66 (d, J = 11.5 Hz, 1H), 4.55 (d, J = 11.5 Hz, 1H), 4.08 (t, J = 4.5 Hz, 1H), 3.87 
(dd, J = 11.0, 4.0 Hz, 1H), 3.71-3.67 (m, 2H), 3.50 (dt, J = 7.0, 4.0 Hz, 1H), 3.38 (s, 3H), 2.18 (s, 
3H), 0.92-0.84 (m, 18H), 0.55 (q, J = 8.0 Hz, 6H), 0.03 (s, 6H); 
13
C NMR (125 MHz, CDCl3) δ 
210.4, 138.7, 128.2, 127.8, 127.4, 87.8, 81.0, 73.1, 72.9, 62.5, 58.7, 27.7, 25.8, 18.1, 6.75, 4.8, -
5.4; HRMS m/z calcd for C26H48O5NaSi2: 519.2938; found: 519.2964. 
 
 (2S,3S,4S,5R)-5-(Benzyloxy)-6-(tert-butyldimethylsilyloxy)-4-
(triethylsilyloxy)-3-methoxyhexane-2-ol: To a 0 °C solution of 0.100 g 
of ketone 93 (0.202 mmol, 1.0 equiv) in 0.404 mL of Et2O was added 
1.61 mL of a .376 M solution of Zn(BH4)2 (0.606 mmol, 3.0 equiv).  The reaction was stirred at 
0 °C for 1 hour before being quenched with saturated aqueous NH4Cl (1 mL), and the mixture 
was extracted with Et2O (3 x 2.0 mL).  The combined organic extracts were dried (Na2SO4), and 
concentrated.  The resulting crude oil was purified by column chromatography (20 % EtOAc in 
hexanes on silica gel) to afford 95 mg (95 %) of the title compound.     [α]22
D
  -9.39 (c 0.49, 
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CHCl3). IR (thin film): 3439, 1641, 1215, 755 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.36-7.25 (m, 
5H), 4.71 (d, J = 12.0 Hz, 1H), 4.64 (d, J = 12.0 Hz, 1H), 4.08 (dd, J = 4.5, 3.0 Hz, 1H), 3.91-
3.84 (m, 1H), 3.81 (dd, J = 10.5, 5.5 Hz, 1H), 3.72 (dd, 10.5, 6.0 Hz, 1H), 3.60 (dt, J = 5.5, 3.0 
Hz, 1H), 3.43 (s, 3H), 3.33 (s, 1H), 3.02 (dd, J = 7.0, 4.5 Hz, 1H), 1.21 (d, J = 6.5 Hz, 3H), 0.95 
(t, J = 6.5 Hz, 9H), 0.90 (s, 9H), 0.61 (q, J = 6.5 Hz, 6H), 0.05 (s, 6H); 
13
C NMR (125 MHz, 
CDCl3) δ 138.5, 128.2, 127.6, 127.5, 85.0, 79.8, 72.8, 71.1, 68.0, 61.7, 59.2, 25.7, 19.9, 18.0, 6.8, 
4.9, -5.4, -5.5; HRMS m/z calcd for C26H50O5NaSi2: 521.3095; found: 521.3105. 
 
 (2S,3S,4S,5R)-5-(Benzyloxy)-6-(tert-butyldimethylsilyloxy)-3-
methoxyhexane-2,4-diol (94): To a 0 °C solution of 2.68 g of alcohol 
(5.37 mmol, 1.0 equiv) in 16.5 mL of a 1:1 mixture of CH2Cl2:MeOH 
was added 1.35 g of PPTS (5.37 mmol, 1.0 equiv).  The reaction was maintained at 0 °C for 45 
minutes.  A solution of saturated aqueous sodium bicarbonate (25 mL) was added, and the 
mixture was extracted with CH2Cl2 (3 x 20 mL). The combined organic extracts were dried 
(Na2SO4), and concentrated.  The resulting crude oil was purified by column chromatography 
(40 % EtOAc in hexanes on silica gel) to afford 1.62 g (79 %) of the title compound.   [α]22
D
  -
16.0 (c 1.01, CHCl3). IR (thin film): 3019, 1215, 1112, 756 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 
7.37-7.27 (m, 5H), 4.77 (d, J = 11.5 Hz, 1H), 4.58 (d, J = 11.5 Hz, 1H), 4.05-3.97 (m, 2H), 3.87 
(dd, J = 11.0, 5.0 Hz, 1H), 3.75 (dd, J = 11.0, 5.0 Hz, 1H), 3.66 (q, J = 5.0 Hz, 1H), 3.47 (s, 3H), 
3.14 (dd, J = 4.5, 3.0 Hz, 1H), 3.05 (d, J = 6.5 Hz, 1H), 3.01 (d, J = 4.5 Hz, 1H), 1.22 (d, J = 6.5 
Hz, 3H), 0.90 (s, 9H), 0.06 (s, 3H), 0.06 (s, 3H); 
13
C NMR (125 MHz, CDCl3) δ 138.0, 128.5, 
127.9, 127.9, 82.8, 79.7, 72.9, 70.8, 67.2, 62.4, 58.3, 25.8, 19.5, 18.2, -5.4, -5.4; HRMS m/z 
calcd for C20H36O5NaSi: 407.2230; found: 407.2224. 
 
 (4S,5S,6S)-5-Methoxy-2,2,4-trimethyl-6-(2–tert-
butyldimethylsilyloxy-(R)-1-benzyloxyethyl)-1,3-dioxane: To a 0 °C 
solution of 1.62 g of diol 94 (4.20 mmol, 1.0 equiv) in 20 mL of CH2Cl2 
was added 2.61 mL of 2,2-dimethoxy propane (21.06 mmol, 5.0 equiv), 
followed by 0.527 g of PPTS (2.10 mmol, 0.5 equiv).  The reaction was maintained at 0 °C for 4 
hours.  A solution of saturated aqueous sodium bicarbonate (20 mL) was added, and the mixture 
was extracted with CH2Cl2 (3 x 20 mL). The combined organic extracts were dried (Na2SO4), 
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and concentrated.  The resulting crude oil was purified by column chromatography (40 % EtOAc 
in hexanes on silica gel) to afford 1.66 g (93 %) of the title compound.   [α]22
D
  +7.10 (c 2.31, 
CHCl3). IR (thin film): 3019, 1215, 763 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.38-7.24 (m, 5H), 
4.75 (d, J = 12.0 Hz, 1H), 4.69 (d, J = 12.0 Hz, 1H), 4.00 (dd, J = 8.0, 3.5 Hz, 1H), 3.84-3.80 (m, 
2H), 3.73-3.67 (m, 2H), 3.37 (s, 3H), 3.16 (dd, J = 5.5, 3.5 Hz, 1H), 1.42 (s, 3H), 1.34 (s, 3H), 
1.33 (d, J = 6.0 Hz, 3H), 0.90 (s, 9H), 0.06 (s, 3H), 0.05 (s, 3H); 
13
C NMR (125 MHz, CDCl3) δ 
139.6, 128.0, 127.6, 127.1, 100.7, 84.2, 80.0, 73.8, 71.4, 69.4, 63.5, 58.2, 25.9, 24.9, 24.0, 21.5, 
18.3, -5.2, -5.4; HRMS m/z calcd for C23H40O5NaSi: 447.2543; found: 447.2534. 
 
 (4S,5S,6S)-5-Methoxy-2,2,4-trimethyl-6-(2–hydroxy-(R)-1-
benzyloxyethyl)-1,3-dioxane: To a 0 °C solution of 1.66 g of silyl ether 
(3.90 mmol, 1.0 equiv) in 13 mL of THF was added 7.8 mL of TBAF (1 M 
solution in hexan, 7.8 mmol, 2.0 equiv).  The reaction was allowed to 
warm to ambient temperature for 4 hours.  A solution of saturated aqueous ammonium chloride 
(20 mL) was added, and the mixture was extracted with Et2O (3 x 20 mL). The combined 
organic extracts were dried (Na2SO4), and concentrated.  The resulting crude oil was purified by 
column chromatography (40 % EtOAc in hexanes on silica gel) to afford 1.07 g (89 %) of the 
title compound. [α]22
D
  + 34.9 (c 0.98, CHCl3). IR (thin film): 3683, 3019, 1521, 1215, 756 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.40-7.25 (m, 5H), 4.87 (d, J = 11.5 Hz, 1H), 4.61 (d, J = 11.5 Hz, 
1H), 4.01 (dd, J = 8.5, 3.0 Hz, 1H), 3.88-3.72 (m, 3H), 3.58-3.52 (m, 1H), 3.37 (s, 3H), 3.15 (dd, 
J = 5.5, 3.0 Hz, 1H), 2.24-2.20 (m, 1H), 1.44 (s, 3H), 1.37 (s, 3H), 1.35 (d, J = 6.5 Hz, 3H); 
13
C 
NMR (125 MHz, CDCl3) δ 138.8, 128.4, 127.8, 127.6, 100.8, 83.7, 79.0, 74.2, 72.2, 69.5, 61.9, 
58.1, 24.9, 23.9, 21.6; HRMS m/z calcd for C17H26O5Na: 333.1678; found: 333.1684. 
 
 
 (3S,4R,5R,6S)-3-(Benzyloxy)-5-methoxy-6-methyltetrahydro-2H-pyran-
2,4-diol (95):  To a room temperature solution of 0.968 g of primary alcohol 
(3.11 mmol, 1.0 equiv) in 19.2 mL of CH2Cl2 was added 0.522 g of solid 
sodium bicarbonate (6.22 mmol, 2.0 equiv), followed by 1.98 g of Des-Martin periodinane (4.66 
mmol, 1.5 equiv).  The reaction was stirred at ambient temperature for 2 hours, before the 
addition of water (20 mL).  The biphasic mixture was seperated and the aqueous layer was 
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extracted with CH2Cl2 (3 x 20 mL).  The combined organic extracts were dried (Na2SO4), and 
concentrated.  The resulting crude oil was passed through a plug of silica with 40 % EtOAc in 
hexanes, and used in the following reaction without further purification.  The crude aldehyde was 
taken up in 10.8 mL of THF, and cooled to 0 °C.  To this solution was added 1.56 mL of 1M 
HCl (1.56 mmol, 0.5 equiv), and the reaction was allowed to warm to ambient temperature, and 
stir for 1 hour.  A solution of saturated aqueous sodium bicarbonate (10 mL) was added, and the 
mixture was extracted with Et2O (3 x 20 mL).  The combined organic extracts were dried 
(Na2SO4), and concentrated.  The resulting crude oil was purified by column chromatography 
(40 to 75 % EtOAc in hexanes on silica gel) to afford 0.519 g (62 %, over two steps) of the title 
compound as a white crystalline solid. [α]22
D
  -28.4 (c 0.31, CHCl3). IR (thin film): 3683, 3019, 
1521, 1423, 1215, 763 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.39-7.27 (m, 5H), 5.16 (br s, 
0.56H), 4.97 (d, J = 14.5 Hz, 0.44H), 4.74-4.67 (m, 2H), 3.95-3.86 (m, 1H), 3.62-3.55 (m, 1H), 
3.57 (s, 3H), 3.42-3.34 (m, 1H), 3.19 (dd, J = 11.5, 9.5 Hz, 0.44Hz), 3.10 (br d, J = 6.5 Hz, 
0.41Hz), 2.86-2.76 (m, 1H), 2.47 (br s, 1H), 1.32 (d, J = 8.0 Hz, 1.4H), 1.27 (d, J = 7.5 Hz, 2.0 
Hz); 
13
C NMR (100 MHz, CDCl3) δ 138.2, 137.5, 128.6(2C), 128.2 (2C), 128.0 (2C), 96.8, 90.6, 
85.1, 84.7, 82.4, 79.8, 76.0, 74.3, 72.9, 72.7, 71.3, 66.5, 60.7, 60.6, 17.9, 17.8; HRMS m/z calcd 
for C14H20O5Na: 291.1208; found: 291.1211. 
 
 (3S,4S,5R,6S)-5-Methoxy-6-methyl-2-(phenylthio)tetrahydro-2H-pyran-
3,4-diol: To a room temperature solution of 100 mg of diol 95 (0.373 mmol, 
1.0 equiv) in 1.24 mL of MeOH was added 39.6 mg of 10% palladium on 
carbon (0.0373 mmol, 10 mol %).  A balloon filled with hydrogen gas was used to purge the 
flask, and the reaction was allowed to stir overnight at ambient temperature.  After 
approximately 24 hours, the reaction was complete by TLC.  The heterogeneous mixture was 
diluted with ethyl acetate, and passed through a pad of celite, and concentrated.  The crude 
material was taken up in 1.28 mL of THF and stirred at ambient temperature.  To this solution 
was added 0.381 mL of thiophenol (3.73 mmol, 10.0 equiv), and 112 mg of triflic acid (0.746 
mmol, 2.0 equiv).  The reaction was allowed to stir at ambient temperature for 40 minutes.  A 
solution of saturated aqueous sodium bicarbonate (5 mL) was added, and the mixture was 
extracted with ethyl acetate (3 x 10 mL).  The combined organic extracts were dried (Na2SO4), 
and concentrated.  The resulting white powder was quickly passed through a plug of silica gel 
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with 80 % EtOAc in hexanes to afford 98.7 mg (99 % crude yield over two steps) of the title 
compound as a white crystalline solid.  The material was used without further purification in the 
next step. 
 
 (3S,4S,5R,6S)-5-Methoxy-6-methyl-2-(phenylthio)-3,4-(t-
butyldimethylsilyloxy) tetrahydro-2H-pyran (87):  To a 0 °C solution of 
0.166 g of diol (0.61 mmol, 1.0 equiv) in 2.5 mL of CH2Cl2 was added 0.426 
mL of 2,6-lutidine (0.392 g, 3.66 mmol, 6.0 equiv), followed by 0.352 mL of t-
butyldimethylsilyl triflate (0.405 g, 1.53 mmol, 2.5 equiv).  The reaction was allowed to proceed 
at temperature for 1 hour before being quenched with saturated aqueous sodium bicarbonate (5.0 
mL), and the mixture was extracted with CH2Cl2 (3 x 10 mL).  The combined organic extracts 
were dried (Na2SO4) and concentrated.  The resulting crude oil was purified by column 
chromatography (10 % EtOAc in hexanes on silica gel) to afford 0.290 g (95 %) of the title 
compound.  The proton spectrum matches the known compound for the alpha anomer.   [α]22
D
  -
125.5 (c 0.72, CHCl3); 
 
 (Z)-Tributyl(3-methoxy-2-methylallyl)stannane (92):  To a −78 °C solution of 
3.61 g of 3-methoxy-2-methylprop-1-ene (41.9 mmol, 1.0 equiv) in 103 mL of 
THF was added 35.9 mL of sec-BuLi (50.3 mmol, 1.4 M in cyclohexane, 1.2 
equiv) followed by 6.09 g of TMEDA (52.04 mmol, 1.25 equiv).  After 15 minutes at −78 °C 
15.0 g of Bu3SnCl (46.09 mmol, 1.1 equiv) was added, and the mixture was allowed to warm to 
room temperature, and stir at ambient temperature for 30 minutes.  The reaction mixture was 
then poured into 200 mL of hexane, and the organic layer was washed with 100 mL of saturated 
aqueous NH4Cl, followed by 100 mL of H2O.  The organic layer was dried with MgSO4, then 
concentrated.  The crude product was partially purified by kugelhrohr distillation under high 
vacuum at approximately 160 °C to yield a mostly pure product containing only the Z-isomer.  
The product was contaminated with tin by-products, however it was used without further 
purification in the subsequent reactions.   
 
 
 
 86 
APPENDIX A: 
1
H AND 
13
C SPECTRA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 87 
 
 
 88 
 
 
 89 
 
 
 90 
 
 
 91 
 
 
 92 
 
 
 93 
 
 
 94 
 
 
 95 
 
 
 96 
 
 
 97 
 
 
 98 
 
 
 99 
 
 
 100 
 
 
 101 
 
 
 102 
 
 
 103 
 
 
 104 
 
 
 105 
 
 
 106 
 
 
 107 
 
 
 108 
 
 
 109 
 
 
 110 
 
 
 111 
 
 
 112 
 
 
 113 
 
 
 114 
 
 
 115 
 
 
 116 
 
 
 117 
 
 
 118 
 
 
 119 
 
 
 120 
 
 
 121 
 
 
 122 
 
 
 123 
 
 
 124 
 
 
 125 
 
 
 126 
 
 
 127 
 
 
 128 
 
 
 129 
 
 
 130 
 
 
 131 
 
 
 132 
 
 
 133 
 
 
 134 
 
 
 135 
 
 
 136 
 
 
 137 
 
 
 138 
 
 
 139 
 
 
 140 
 
 
 141 
 
 
 142 
 
 
 143 
 
 
 144 
 
 
 145 
 
 
 146 
 
 
 147 
 
 
 148 
 
 
 149 
 
 
 150 
 
 
 151 
 
 
 152 
 
 
 153 
 
 
 154 
 
 
 155 
 
 
 156 
 
 
 157 
BIBLIOGRAPHY 
 
(1) Kim, J. W.; Adachi, H.; Shin-Ya, K.; Hayakawa, Y.; Seto, H. "Apoptolidin, a new 
apoptosis inducer in transformed cells from Nocardiopsis sp.. " J. Antibiot. 1997, 50, 3. 
 
(2) Hayakawa, Y.; Kim, J. W.; Adachi, H.; Shin-ya, K.; Fujita, K. i.; Seto, H. "Structure of 
Apoptolidin, a Specific Apoptosis Inducer in Transformed Cells" J. Am. Chem. Soc. 
1998, 120, 3524-3525. 
 
(3) Salomon, A. R.; Voehringer, D. W.; Herzenberg, L. A.; Khosla, C. "Understanding and 
exploiting the mechanistic basis for selectivity of polyketide inhibitors of F0F1-ATPase" 
PNAS 2000, 97, 14766-14771. 
 
(4) Nicolaou, K. C.; Li, Y.; Fylaktakidou, K. C.; Mitchell, H. J.; Sugita, K. "Total Synthesis 
of Apoptolidin: Part 2. Coupling of Key Building Blocks and Completion of the 
Synthesis" Angew. Chem. Int. Ed. 2001, 40, 3854-3857. 
 
(5) Wender, P. A.; Sukopp, M.; Longcore, K. "Apoptolidins B and C: Isolation, Structure 
Determination, and Biological Activity" Org. Lett. 2005, 7, 3025-3028. 
 
(6) Wender, P. A.; Longcore, K. E. "Apoptolidins E and F, New Glycosylated Macrolactones 
Isolated from Nocardiopsis sp" Org. Lett. 2009, 11, 5474-5477. 
 
(7) Wender, P. A.; Jankowski, O. D.; Longcore, K.; Tabet, E. A.; Seto, H.; Tomikawa, T. 
"Correlation of F0F1-ATPase Inhibition and Antiproliferative Activity of Apoptolidin 
Analogues" Org. Lett. 2006, 8, 589-592. 
 
(8) Wender, P. A.; Jankowski, O. D.; Tabet, E. A.; Seto, H. "Facile Synthetic Access to and 
Biological Evaluation of the Macrocyclic Core of Apoptolidin" Org. Lett. 2003, 5, 2299-
2302. 
 
(9) Wender, P. A.; Jankowski, O. D.; Tabet, E. A.; Seto, H. "Toward a Structure-Activity 
Relationship for Apoptolidin: Selective Functionalization of the Hydroxyl Group Array" 
Org. Lett. 2003, 5, 487-490. 
 
 158 
(10) Vargo, T. R.; Hale, J. S.; Nelson, S. G. "Catalytic Asymmetric Aldol Equivalents in the 
Enantioselective Synthesis of the Apoptolidin C Aglycone" Angew. Chem., Int. Ed., 49, 
8678-8681. 
 
(11) Nicolaou, K. C.; Li, Y.; Fylaktakidou, K. C.; Mitchell, H. J.; Wei, H.-X.; Weyershausen, 
B. "Total Synthesis of Apoptolidin: Part 1. Retrosynthetic Analysis and Construction of 
Building Blocks" Angew. Chem. Int. Ed. 2001, 40, 3849-3854. 
 
(12) Nicolaou, K. C.; Fylaktakidou, K. C.; Monenschein, H.; Li, Y.; Weyershausen, B.; 
Mitchell, H. J.; Wei, H. x.; Guntupalli, P.; Hepworth, D.; Sugita, K. "Total Synthesis of 
Apoptolidin: Construction of Enantiomerically Pure Fragments" J. Am. Chem. Soc. 2003, 
125, 15433-15442. 
 
(13) Nicolaou, K. C.; Li, Y.; Sugita, K.; Monenschein, H.; Guntupalli, P.; Mitchell, H. J.; 
Fylaktakidou, K. C.; Vourloumis, D.; Giannakakou, P.; O'Brate, A. "Total Synthesis of 
Apoptolidin: Completion of the Synthesis and Analogue Synthesis and Evaluation" J. 
Am. Chem. Soc. 2003, 125, 15443-15454. 
 
(14) Nicolaou, K. C.; Li, Y.; Weyershausen, B.; Wei, H.-x. "Synthesis of the macrocyclic core 
of apoptolidin" Chem. Comm. 2000, 307-308. 
 
(15) Wehlan, H.; Dauber, M.; Fernaud, M. T. M.; Schuppan, J.; Mahrwald, R.; Ziemer, B.; 
Garcia, M. E. J.; Koert, U. "Total Synthesis of Apoptolidin" Angew. Chem., Int. Ed. 
2004, 43, 4597-4601. 
 
(16) Wehlan, H.; Dauber, M.; Fernaud, M. T. M.; Schuppan, J.; Keiper, S.; Mahrwald, R.; 
Garcia, M. E. J.; Koert, U. "Apoptolidin A: Total Synthesis and Partially Glycosylated 
Analogues" Chem.--Eur. J. 2006, 12, 7378-7397. 
 
(17) Schuppan, J.; Wehlan, H.; Keiper, S.; Koert, U. "Synthesis of Apoptolidinone" Angew. 
Chem., Int. Ed. 2001, 40, 2063-2066. 
 
(18) Schuppan, J.; Wehlan, H.; Keiper, S.; Koert, U. "Apoptolidinone A: Synthesis of the 
Apoptolidin A Aglycone" Chem.--Eur. J. 2006, 12, 7364-7377. 
 
(19) Schuppan, J.; Ziemer, B.; Koert, U. "Stereoselective synthesis of the C18-C28 fragment 
of apoptolidin" Tetrahedron Lett. 2000, 41, 621-624. 
 
(20) Crimmins, M. T.; Christie, H. S.; Chaudhary, K.; Long, A. "Enantioselective Synthesis of 
Apoptolidinone: Exploiting the Versatility of Thiazolidinethione Chiral Auxiliaries" J. 
Am. Chem. Soc. 2005, 127, 13810-13812. 
 
(21) Crimmins, M. T.; Christie, H. S.; Long, A.; Chaudhary, K. "Total Synthesis of 
Apoptolidin A" Org. Lett. 2009, 11, 831-834. 
 
 159 
(22) Crimmins, M. T.; Long, A. "Enantioselective Synthesis of Apoptolidin Sugars" Org. Lett. 
2005, 7, 4157-4160. 
 
(23) Wu, B.; Liu, Q.; Jin, B.; Qu, T.; Sulikowski, G. A. "Studies on the Synthesis of 
Apoptolidin: Progress on the Stereocontrolled Assembly of the Pseudo Aglycone of 
Apoptolidin" Eur. J. Org. Chem. 2006, 2006, 277-284. 
 
(24) Wu, B.; Liu, Q.; Sulikowski, G. A. "Total Synthesis of Apoptolidinone" Angew. Chem., 
Int. Ed. 2004, 43, 6673-6675. 
 
(25) Pennington, J. D.; Williams, H. J.; Salomon, A. R.; Sulikowski, G. A. "Toward a Stable 
Apoptolidin Derivative: Identification of Isoapoptolidin and Selective Deglycosylation of 
Apoptolidin" Org. Lett. 2002, 4, 3823-3825. 
 
(26) Sulikowski, G. A.; Lee, W. M.; Jin, B.; Wu, B. "Synthesis of the Apoptosis Inducing 
Agent Apoptolidin. Assembly of the C(16)-C(28) Fragment" Org. Lett. 2000, 2, 1439-
1442. 
 
(27) Handa, M.; Scheidt, K. A.; Bossart, M.; Zheng, N.; Roush, W. R. "Studies on the 
Synthesis of Apoptolidin A. 1. Synthesis of the C(1)-C(11) Fragment" J. Org. Chem. 
2008, 73, 1031-1035. 
 
(28) Handa, M.; Smith, W. J.; Roush, W. R. "Studies on the Synthesis of Apoptolidin A. 2. 
Synthesis of the Disaccharide Unit" J. Org. Chem. 2008, 73, 1036-1039. 
 
(29) Crimmins, M. T.; Chaudhary, K. "Titanium Enolates of Thiazolidinethione Chiral 
Auxiliaries: Versatile Tools for Asymmetric Aldol Additions" Org. Lett. 2000, 2, 775-
777. 
 
(30) T. Davies-Coleman, M.; J. Garson, M. "Marine polypropionates" Nat. Prod. Rep. 1998, 
15, 477-493. 
 
(31) Schetter, B.; Mahrwald, R. "Modern Aldol Methods for the Total Synthesis of 
Polyketides" Angew. Chem., Int. Ed. 2006, 45, 7506-7525. 
 
(32) Gu, H.; Xu, W. M.; Kinstle, T. H. "Efficient synthesis of 8,11-dimethylene-
bicyclo[5.3.1]undecan-2-one" Tetrahedron Lett. 2005, 46, 6449-6451. 
 
(33) Jones, E. R. H.; Eglinton, G.; Whiting, M. C. "4-pentyn-1-ol" Org. Syn. 1953, 33, 68-70. 
 
(34) Dickman, D. A.; Meyers, A. I. "Reduction of alpha-amino Acids: L-Valinol" Org. Syn. 
1985, 63, 136-139. 
 
(35) Nelson, S. G.; Zhu, C.; Shen, X. "Catalytic Asymmetric Acyl Halide-Aldehyde 
Cyclocondensation Reactions of Substituted Ketenes" Journal of the American Chemical 
Society 2003, 126, 14-15. 
 160 
 
(36) Daumas, M.; Vo-Quang, Y.; Vo-Quang, L.; Le Goffic, F. "A New and Efficient 
Heterogeneous System for the Oxidative Cleavage of 1,2-Diols and the Oxidation of 
Hydroquinones" Synthesis 1989, 1989, 64,65. 
 
(37) Nelson, S. G.; Mills, P. M. "Catalytic Asymmetric Acyl Halide-Aldehyde 
Cyclocondensation Reaction" Org. Syn. 2005, 82, 170-174. 
 
(38) Nelson, S. G.; Zhu, C.; Shen, X. "Catalytic Asymmetric Acyl Halide-Aldehyde 
Cyclocondensation Reactions of Substituted Ketenes" J. Am. Chem. Soc. 2004, 126, 14-
15. 
 
(39) Zhu, C.; Shen, X.; Nelson, S. G. "Cinchona Alkaloid-Lewis Acid Catalyst Systems for 
Enantioselective Ketene-Aldehyde Cycloadditions" J. Am. Chem. Soc. 2004, 126, 5352-
5353. 
 
(40) Shen, X.; Wasmuth, A. S.; Zhao, J.; Zhu, C.; Nelson, S. G. "Catalytic Asymmetric 
Assembly of Stereodefined Propionate Units: An Enantioselective Total Synthesis of (-)-
Pironetin" J. Am. Chem. Soc. 2006, 128, 7438-7439. 
 
(41) Shen, X. Graduate Thesis, University of Pittsburgh, 2007. 
 
(42) Roush, W. R. "Concerning the diastereofacial selectivity of the aldol reactions of .alpha.-
methyl chiral aldehydes and lithium and boron propionate enolates" J. Org. Chem. 1991, 
56, 4151-4157. 
 
(43) Calter, M. A. "Catalytic, Asymmetric Dimerization of Methylketene" J. Org. Chem. 
1996, 61, 8006-8007. 
 
(44) Evans, D. A.; Cote, B.; Coleman, P. J.; Connell, B. T. "1,5-Asymmetric Induction in 
Boron-Mediated alpha-Alkoxy Methyl Ketone Aldol Addition Reactions" J. Am. Chem. 
Soc. 2003, 125, 10893-10898. 
 
(45) Chérest, M.; Felkin, H.; Prudent, N. "Torsional strain involving partial bonds. The 
stereochemistry of the lithium aluminium hydride reduction of some simple open-chain 
ketones" Tetrahedron Lett. 1968, 9, 2199-2204. 
 
(46) Lodge, E. P.; Heathcock, C. H. "Acyclic stereoselection. 40. Steric effects, as well as 
sigma-orbital energies, are important in diastereoface differentiation in additions to chiral 
aldehydes" J. Am. Chem. Soc. 1987, 109, 3353-3361. 
 
(47) Lodge, E. P.; Heathcock, C. H. "Acyclic stereoselection. 39. The origin of diastereofacial 
selectivity in additions to chiral aldehydes and ketones: trajectory analysis" J. Am. Chem. 
Soc. 1987, 109, 2819-2820. 
 
 161 
(48) Evans, D. A.; Dart, M. J.; Duffy, J. L.; Yang, M. G. "A Stereochemical Model for 
Merged 1,2- and 1,3-Asymmetric Induction in Diastereoselective Mukaiyama Aldol 
Addition Reactions and Related Processes" J. Am. Chem. Soc. 1996, 118, 4322-4343. 
 
(49) Keck, G. E.; Castellino, S. "On the origins of stereoselectivity in chelation controlled 
nucleophilic additions to .beta.-alkoxy aldehydes: solution structures of Lewis acid 
complexes via NMR spectroscopy" J. Am. Chem. Soc. 1986, 108, 3847-3849. 
 
(50) Keck, G. E.; Castellino, S.; Wiley, M. R. "Dramatic effects of oxygen substituents on 1,3-
asymmetric induction in additions of allyltriphenylstannane to .beta.-alkoxy aldehydes: a 
chemical and spectroscopic investigation" J. Org. Chem. 1986, 51, 5478-5480. 
 
(51) Reetz, M. T. "Chelation or Non-Chelation Control in Addition Reactions of Chiral α- and 
β- Alkoxy Carbonyl Compounds [New Synthetic Methods (44)]" Angew. Chem. Int. Ed. 
1984, 23, 556-569. 
 
(52) Cram, D. J.; Kopecky, K. R. "Studies in Stereochemistry. XXX. Models for Steric 
Control of Asymmetric Induction1" J. Am. Chem. Soc. 1959, 81, 2748-2755. 
 
(53) Goodman, J. M.; Paton, R. S. "Enantioselectivity in the boron aldol reactions of methyl 
ketones" Chem. Comm. 2007, 2124-2126. 
 
(54) Denmark, S. E.; Fujimori, S.; Pham, S. M. "Lewis Base Catalyzed Aldol Additions of 
Chiral Trichlorosilyl Enolates and Silyl Enol Ethers" J. Org. Chem. 2005, 70, 10823-
10840. 
 
(55) Paterson, I.; Findlay, A. D.; Florence, G. J. "Total Synthesis and Stereochemical 
Reassignment of (+)-Dolastatin 19" Org. Lett. 2006, 8, 2131-2134. 
 
(56) Paton, R. S.; Goodman, J. M. "1,5-Anti Stereocontrol in the Boron-Mediated Aldol 
Reactions of alpha-Alkoxy Methyl Ketones: The Role of the Formyl Hydrogen Bond" J. 
Org. Chem. 2008, 73, 1253-1263. 
 
(57) Dias, L. C.; Bau, R. Z.; de Sousa, M. A.; Zukerman-Schpector, J. "High 1,5-Anti 
Stereoinduction in Boron-Mediated Aldol Reactions of Methyl Ketones" Org. Lett. 2002, 
4, 4325-4327. 
 
(58) Evans, D. A.; Kim, A. S.; Metternich, R.; Novack, V. J. "General Strategies toward the 
Syntheses of Macrolide Antibiotics. The Total Syntheses of 6-Deoxyerythronolide B and 
Oleandolide" J. Am. Chem. Soc. 1998, 120, 5921-5942. 
 
(59) Srogl, J.; Allred, G. D.; Liebeskind, L. S. "Sulfonium Salts. Participants par Excellence in 
Metal-Catalyzed Carbon-Carbon Bond-Forming Reactions" J. Am. Chem. Soc. 1997, 119, 
12376-12377. 
 
 162 
(60) Smith, A. B.; Dong, S. "An Efficient, Second-Generation Synthesis of the Signature 
Dioxabicyclo[3.2.1]octane Core of (+)-Sorangicin A and Elaboration of the (Z,Z,E)-
Triene Acid System" Org. Lett. 2009, 11, 1099-1102. 
 
(61) Nelson, S. G.; Cheung, W. S.; Kassick, A. J.; Hilfiker, M. A. "A de Novo 
Enantioselective Total Synthesis of (-)-Laulimalide" J. Am. Chem. Soc. 2002, 124, 
13654-13655. 
 
(62) Nelson, S. G.; Unpublished Results, 2009, University of Pittsburgh 
 
(63) Kassick, A. J., University of Pittsburgh, 2004. 
 
(64) Davis, F. A.; Vishwakarma, L. C.; Billmers, J. G.; Finn, J. "Synthesis of .alpha.-
hydroxycarbonyl compounds (acyloins): direct oxidation of enolates using 2-
sulfonyloxaziridines" J. Am. Chem. Soc. 1984, 49, 3241-3243. 
 
(65) Carpenter, J.; Northrup, A. B.; Chung, d.; Wiener, J. J. M.; Kim, S.-G.; MacMillan, D. 
W. C. "Total Synthesis and Structural Revision of Callipeltoside C" Angew. Chem. Int. 
Ed. 2008, 47, 3568-3572. 
 
(66) Northrup, A. B.; MacMillan, D. W. C. "Two-Step Synthesis of Carbohydrates by 
Selective Aldol Reactions" Science 2004, 305, 1752-1755. 
 
(67) Northrup, A. B.; Mangion, I. K.; Hettche, F.; MacMillan, D. W. C. "Enantioselective 
Organocatalytic Direct Aldol Reactions of α-Oxyaldehydes: Step One in a Two-Step 
Synthesis of Carbohydrates" Angew. Chem. 2004, 116, 2204-2206. 
 
(68) Keck, G. E.; Abbott, D. E.; Wiley, M. R. "New allylstannanes for the connective 
construction of monoprotected vicinal diols" Tetrahedron Lett. 1987, 28, 139-142. 
 
(69) Mukaiyama, T.; Shiina, I.; Iwadare, H.; Saitoh, M.; Nishimura, T.; Ohkawa, N.; Sakoh, 
H.; Nishimura, K.; Tani, Y.-i.; Hasegawa, M.; Yamada, K.; Saitoh, K. "Asymmetric 
Total Synthesis of Taxol" Chem.–Eur. J. 1999, 5, 121-161. 
 
 
 
